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ABSTRACT 
Extracellular vesicles (EVs) are nanometer sized particles released from all cells. 
EVs are found in all biological fluids, including cerebrospinal fluid (CSF) and blood. 
EVs modulate intercellular communication through the transfer of nucleic acids and 
proteins from donor to recipient cells. During early postnatal neurogenesis, 
subventricular zone (SVZ) neural stem cells (NSCs) asymmetrically divide to give 
rise to neuroblasts that migrate along the rostral migratory stream (RMS) and 
populate the olfactory bulb (OB). Other, non-neuronal cells populate the SVZ, such 
as microglia and endothelial cells. Microglia have been shown to regulate SVZ 
NSCs, but it remains unclear if this communication is bidirectional. The purpose of 
this study was to determine if SVZ NSCs release EVs and what physiological 
impact this has on postnatal SVZ development. First, we generated a protocol in 
which SVZ NSCs were placed in culture and EVs were isolated from NSC 
conditioned media. To study EVs in vivo, EVs were labeled with DiI and 
transplanted into the SVZ of neonatal mice. Immunocytochemistry, 
immunohistochemistry, and electron microscopy were used to confirm the isolation 
and transplantation of NSC EVs. Using this methodology, SVZ NSC EVs were 
transplanted into the lateral ventricles of neonatal mice. We found a majority of DiI 
particles coalesced with Iba1-positive microglia in the SVZ. Furthermore, Iba1-
positive microglia underwent a morphological shift from a stellate to rounded 
phenotype. RNA sequencing and analysis of EV treated microglia revealed that 
immune system processes and inflammatory responses were the most highly 
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enriched and represented terms. Small RNA sequencing of NSC EVs uncovered 
families of miRNA, such as Let-7, that have been shown to regulate microglia 
physiology and morphology. The upregulation of inflammatory response 
transcripts included interleukin 1α (IL-1α), IL-1β, and IL-6. In agreement with RNA 
sequencing data, Luminex assays revealed cytokines, such as IL-1α, IL-1β, and 
IL-6, were significantly upregulated in treated microglia. EV-depleted microglia 
media was transplanted into the lateral ventricles of neonatal mice, and media 
collected from EV-treated microglia reduced SVZ NSC proliferation. To further 
investigate if SVZ NSCs release EVs in vivo, we generated a transgenic model 
system in which EV marker protein tetraspanin CD9 was fused to Turbo-GFP 
(CD9-GFP), which is derived from the copepod Pontellina plumata.  CD9-GFP was 
inserted downstream of a STOP codon flanked by loxP sites. CD9-GFP was found 
in Nestin-positive cells in the SVZ of transgenic mice electroporated with Cre-
recombinase. Taken together, our data supports the release of EVs from SVZ 
NSCs both in vivo and in vitro. Furthermore, EVs released from SVZ NSCs 
regulate microglia during early postnatal development.  
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CHAPTER ONE 
INTRODUCTION 
Extracellular Vesicles 
Extracellular Vesicles (EVs) are primarily membranous-derived particles 
ranging in size from 30 nm – 500 nm (Cocucci and Meldolesi 2015; Théry, Zitvogel, 
and Amigorena 2002; Maas, Breakefield, and Weaver 2017). EVs are found in 
most biological fluids, including cerebrospinal fluid (CSF), blood, urine and saliva, 
and carry an array of biologically active cargo such as proteins, lipids and RNA 
(Valadi et al. 2007; Ramachandran and Palanisamy 2012; Raposo and Stoorvogel 
2013; Théry, Zitvogel, and Amigorena 2002; Wei et al. 2017). Three types of EVs 
have been described: exosomes, microvesicles and exomeres (H. Zhang et al. 
2018; Théry, Zitvogel, and Amigorena 2002; Cocucci and Meldolesi 2015). 
Exosomes are generated from the inward budding of an early endosome to 
generate intraluminal vesicles (ILVs) that populate multivesicular bodies (MVBs; 
Figure 1A-C) (Théry, Zitvogel, and Amigorena 2002).  MVB biogenesis relies on 
the ESCRT (endosomal sorting complex required for transport) pathway. 
Comprised of five complexes, the ESCRT pathway intricately delegates specific 
steps in MVB biogenesis to each of the complexes (Henne, Buchkovich, and Emr 
2011). ESCRT-0 is required at the site of initiation to generate the early endosome 
(Henne, Buchkovich, and Emr 2011). Invagination of the cell membrane to 
generate the early endosome requires the recruitment of ESCRT complexes I and 
II by ESCRT-0 (Bache et al. 2003; Lu et al. 2003; Katzmann et al. 2003). ESCRT-
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II is required to initiate ESCRT-III complex (Booth et al. 2006; Babst et al. 2002; 
Langelier et al. 2006). ESCRT-III tethers the outer edges of the early endosome 
which has been suggested to allow for Vps4-Vta1 complex (V complex) to 
assemble and complete the scission of the endosome (Henne, Buchkovich, and 
Emr 2011). Interestingly, protein cargo sorting into ILVs can occur in an ESCRT-
dependent or -independent manner (van Niel et al. 2011). MVBs then fuse with the 
cell membrane and release the vesicles, now called exosomes, into the 
extracellular space (Figure 1D). Although it is unclear precisely how MVBs are 
sequestered to, dock and fuse with the cell membrane, many studies point to the 
involvement of RAB GTPases. The first example of RAB GTPase involvement in 
exosome secretion came from studies utilizing reticulocyte cell lines which 
demonstrated that Rab11 was required for exosome release (Savina, Vidal, and 
Colombo 2002). Rab27a and Rab27b have also been shown to reduce exosome 
release from cells by inhibiting the targeting and docking of MVBs to the plasma 
membrane (Ostrowski et al. 2010; A. Bobrie et al. 2012; Peinado et al. 2012). 
Another study discovered that Rab-GTPase activating proteins TBC1D10A-C in 
oligodendrocytes target Rab35 function which is required for exosome release 
(Hsu et al. 2010). Reduction of Rab35 function resulted in the accumulation of ILVs 
in MVBs within the cytoplasm, thus suggesting Rab35’s function in docking at the 
plasma membrane (Hsu et al. 2010). Conversely, microvesicles are generated 
following scission of the outward budding of the cell membrane (Figure 1H) 
(Cocucci and Meldolesi 2015). Exosomes are characteristically smaller in size (< 
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150 nm), whereas microvesicles are larger in size (200-500 nm) (Maas, 
Breakefield, and Weaver 2017). Finally, non-membranous EVs, called exomeres, 
are protein-like vesicles comprised of metabolic, translational and coagulation 
regulating proteins (H. Zhang et al. 2018). Elucidating the biogenesis of these non-
membranous vesicles will be critical to understand their physiological roles (H. 
Zhang et al. 2018).  
Extracellular Vesicle Cargo 
 EVs carry an array of biological material such as miRNA, mRNA and 
protein (Valadi et al. 2007; Ramachandran and Palanisamy 2012; Raposo and 
Stoorvogel 2013; Théry, Zitvogel, and Amigorena 2002; Wei et al. 2017). 
Historically, EVs were thought to act as a cellular disposal system in which 
damaged or unnecessary RNA and protein were shuttled into and released from 
the cell (Harding, Heuser, and Stahl 1983). However, recent discussion has shifted 
to favor a more intentional role of EVs and their cargo. To uncover the role EVs 
play in cellular communication, EV content has been investigated. Studies have 
ranged from small scale hypothesis driven experimentation to next generation 
RNA sequencing and microarrays to proteomics and lipidomic studies.  
Since the discovery that EVs can transfer functional miRNA and RNA from 
donor to recipient cells, studies have focused on the regulatory roles of EVs in both 
development and disease. However, many questions remain regarding EV miRNA 
quantity, biological significance and the functional transfer of miRNA between cells 
(Figure 1E-F). Predominately, circulating miRNAs are bound to protein 
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complexes, such as Ago2, with only a small subset of miRNAs found within 
exosomes (Melo et al. 2014; Arroyo et al. 2011). Quantity of EV content per EV 
was discovered to follow a low occupancy model (Chevillet et al. 2014). It is 
estimated that for every 100 circulating exosomes, only one will contain miRNAs, 
but for non-circulating exosomes, this ratio is higher (1:10) (Chevillet et al. 2014). 
miRNA sorting is dependent on miRNA consensus sequences or binding motifs, 
miRNA shuttling proteins and endogenous target mRNA levels (Melo et al. 2014; 
Squadrito et al. 2014). Heterogenous nuclear ribonucleoprotein A2B1 
(hnrnpA2B1) sorts miRNA into exosomes through specific motifs found on EV 
miRNAs (Villarroya-Beltri et al. 2013). Sorting of miRNAs can be altered by 
mutagenesis of the binding motif or through the down-regulation or loss of 
hnrnpa2b1 (Villarroya-Beltri et al. 2013). In breast cancer (BC) cells, miRNA 
processing components were identified within exosomes released from BC cells 
(Melo et al. 2014). Exosomes were shown to process pre-miRNA utilizing Dicer, 
AGO2 and the RISC complex in a cell-independent manner (Melo et al. 2014). 
Additionally, miRNA sorting relies on the level of endogenous miRNAs. If the target 
mRNA transcript is elevated within the donor cell, then the miRNA which 
recognizes that target mRNA will less frequently be sorted into exosomes 
(Squadrito et al. 2014). Therefore, the converse is true, meaning if target 
transcripts are low and miRNAs are not actively binding to their targets, they are 
shuttled into ILVs and released from the cell encapsulated in exosomes. miRNAs 
are more readily found in exosomes compared to microvesicles. For instance, in 
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adult CSF, miRNAs found in exosomes and microvesicles varied greatly with 
exosomes containing the majority of circulating miRNAs (Akers et al. 2015). Given 
that exosomes are generated within the cytoplasm of the cell and thus have greater 
exposure to endogenous miRNAs than microvesicles, it is not surprising that 
exosomes, and not microvesicles, carry the majority of EV associated miRNAs. 
miRNAs have the capacity to regulate translation and can work in combination, 
thus researchers have focused their studies on EVs role in development and 
disease. During development, miRNAs, such as miR-124 and miR-9, have been 
identified within EVs in the central nervous system and from mesenchymal stem 
cells, respectively (Cao, Pfaff, and Gage 2007; Visvanathan et al. 2007; Feliciano 
et al. 2014). Since embryonic neuronal differentiation requires the regulatory 
actions of both these miRNAs and since fibroblast can be re-programmed into 
neurons following co-expression of both miR-9 and miR-124, it is possible that 
combinations of EV encapsulated miRNAs can regulate cell fate (Yoo et al. 2009, 
2011). Through the utilization of EVs, distally located cells could coordinate 
development without direct cell-to-cell transfer of molecular signals. EV miRNAs 
have also been shown to contribute to the onset and progression of disease. For 
example, in patients with metastatic breast cancer, exosomes containing miR-
181c were found to fuse with the cells constructing the blood brain barrier (BBB), 
and through miRNA dysregulation, resulted in the break-down and subsequent 
metastasis of breast cancer cells in the brain (Tominaga et al. 2015). Additionally, 
EVs released from cancer cells in vivo have the potential to be used as a diagnostic 
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and biomarker tool, and bioengineered EVs can be generated as a more potent 
and specific therapeutic (EL Andaloussi et al. 2013). In addition to miRNAs, EVs 
contain other non-coding RNAs, mRNA and even DNA, although generally DNA is 
not found in EVs (Maas, Breakefield, and Weaver 2017).  
EVs also transport a wide variety of proteins. Specifically, research has 
identified a group of proteins referred to as EV marker proteins that are highly 
abundant in exosomes, microvesicles or both. Tetraspanins, such as CD9, CD63 
and CD81, are composed of four transmembrane domains (Andreu and Yáñez-
Mó 2014). These proteins cluster together to form microdomains at the cell surface 
and thus are found enriched in both exosomes and microvesicles (Théry et al. 
2006; Raposo and Stoorvogel 2013; Andreu and Yáñez-Mó 2014). Additionally, 
EVs are associated with proteins specific to lipid rafts including flotillin and 
glycosylphosphatidylinositol-anchored proteins (Müller et al. 2009; López-Cobo, 
Campos-Silva, and Valés-Gómez 2016). Exosomes are also enriched in 
sphingomyelin and cholesterol (Kosaka et al. 2013; Bianco et al. 2009). Other than 
protein identifiers, EVs carry protein cargo specific to their cell of origin. For 
instance, neural stem/progenitor cells (NSCs) from the subventricular zone (SVZ) 
of adult mice release metabolically active EVs containing asparaginase (Iraci et al. 
2017). Another studied identified the release of interferon gamma (IFN-gamma) on 
the surface of NSC EVs activated Stat1 signaling in target cells (Cossetti et al. 
2014). EVs also contribute to the pathogenesis of certain diseases, including but 
not limited to Alzheimer’s disease and cancer (Rajendran et al. 2006). However, 
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how protein cargo is sorted into EVs has yet to be fully defined. Post-translational 
modifications of EV protein cargo may act as specific molecular signatures, such 
as ubiquitinoylation or SUMOylation, which might allow for protein sorting into EVs 
(Villarroya-Beltri et al. 2013). 
Extracellular Vesicles and Disease 
EVs have a role in the pathogenesis of neurodegenerative diseases and 
cancer. Most cells release EVs at a pre-determined rate; however, cells under 
stress, such as hypoxia, DNA damage, cellular senesce or exposure to exogenous 
pathogens, increase their rate of release. EVs potentially play a pathogenic role in 
some neurodegenerative diseases. For instance, Alzheimer’s disease arises from 
the aggregation of amyloid-β plaques in neurons and the secretion of abnormally 
processed Tau protein. Initially, exosomes isolated from HeLa cells expressing a 
mutant Amyloid Precursor Protein (APP) were found to be enriched in amyloid-β 
proteins (Rajendran et al. 2006). From the CSF of Alzheimer’s patients, isolated 
EVs were found to be enriched for tau protein (Saman et al. 2012). In models of 
Parkinson’s disease, α-synuclein was discovered in exosomes (Emmanouilidou et 
al. 2010). Exosome conditioned media was sufficient to induce neuronal death, but 
immunodepletion of α-synuclein reversed this finding (Emmanouilidou et al. 2010). 
Since α-synuclein was found in exosomes, conditioned media depleted of 
exosomes would be required in addition to and independent of immunodepletion 
to prove indeed exosomes were the causal factor in the neuronal cell death.  EVs 
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have also been implicated in the pathogenesis of prion-associated 
neurodegeneration (Fevrier et al. 2004; L. Vella et al. 2007).  
 Cancer cells also release EVs that promote angiogenesis, regulate 
immune cells and prime tissue for metastasis (Becker et al. 2016; Cantaluppi et al. 
2014). A hallmark characteristic of tumors is their ability to generate their own 
blood supply (Webber, Yeung, and Clayton 2015; Plaks, Kong, and Werb 2015). 
Earlier studies identified the release of pro-angiogenic factors from cancer cells, 
but recent data demonstrates that EVs also contribute to the angiogenic potential 
of tumors (Todorova et al. 2017). EVs containing tetraspanin-8 (tspn-8) released 
from rat adenocarcinoma cells induced angiogenesis by up-regulating VEGF and 
VEGF-R2 in endothelial cells (Nazarenko et al. 2010). Another study identified that 
EVs released from colorectal cancer cells promoted endothelial cell proliferation 
and migration through ERK1/2 and JNK signaling pathways via Egr-1 activation 
(Yoon et al. 2014). Pro-angiogenic miRNAs have also been identified in EVs 
(Feliciano et al. 2014; Skog et al. 2008). Immunomodulatory alterations allow for 
cancer cells to persist without infraction in vivo. Because of their ability to transfer 
bioactive molecules between cells, EVs released from cancer cells are thought to 
have immunoregulatory functions (Robbins and Morelli 2014). EVs transport 
immunosuppressive ligands and ncRNA, such as programmed cell death 1 ligand 
(PD-L1) and hY4 ncRNA, from cancer to immune cells thus suppressing monocyte 
function and supporting tumor growth (G. Chen et al. 2018; Haderk et al. 2017; 
Ricklefs et al. 2018). In addition to angiogenic and immunomodulatory roles, 
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cancer-associated EVs self-promote tumor growth and prime the pre-metastatic 
niche to promote metastasis (Tominaga et al. 2015; Y. Zhang and Wang 2015; Liu 
et al. 2016; Peinado et al. 2012; Angélique Bobrie et al. 2012). For example, miR-
122 containing exosomes released from breast cancer cells suppressed glucose 
metabolism of non-tumor cells in the pre-metastatic niche (Fong et al. 2015). EVs 
released from cancer cells act as a homing mechanism in cancer metastasis in an 
organ specific manner (Hoshino et al. 2015). When transplanted into nude mice, 
exosomes released from tissue-specific cancer cells preferentially target and 
prime their tissue of origin for metastasis (Hoshino et al. 2015). Interestingly, pre-
treatment with exosomes isolated from lung-tropic cancer cells changed the 
metastatic potential of bone-trophic tumor cells, thus exosomes have the capacity 
to influence the metastatic pattern of cancer cells (Hoshino et al. 2015). Cancer 
exosomes also promote tumor growth. Exosomes released from glioblastoma cells 
were capable of promoting proliferation of tumor cells in vitro (Skog et al. 2008). 
Additionally, these exosomes contained pro-angiogenic proteins capable of 
eliciting tubule formation of endothelial cells within the cancer niche (Skog et al. 
2008). Taken together, these studies indicate a fundamental role for EVs in the 
pathogenesis of disease.   
Biomarkers and Designer Vesicles:  
Almost all cell types release EVs which carry a unique molecular profile that 
can be traced back to its cell of origin. Interestingly, one study identified the 
enrichment of low-abundance miRNA in exosomes, meaning that miRNA sorting 
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into exosomes is not random, but rather a calculated effort by the cell (Koppers-
Lalic et al. 2014). Profiling EVs released from various types of cancers will 
potentially allow for the use of EVs as a tool for diagnosis. In the case of cancer, 
most diagnoses rely primarily on tissue biopsies. Whereas EVs offer a sensitive, 
non-invasive option which may increase cancer detection at an earlier stage. One 
study isolated exosomes from the urine of prostate cancer patients and were able 
to identify tumor-specific mRNA biomarkers in the exosomes (Nilsson et al. 2009). 
Other studies have utilized exosomes as potential biomarkers of both breast and 
ovarian cancer through the identification of cancer specific miRNA and protein, 
respectively (Corcoran et al. 2011; Li et al. 2009).  
Since the discovery of pro-neurodegenerative miRNAs and proteins in EVs 
isolated from the CSF of patients, researchers have identified the potential of EVs 
as biomarkers of neurogenic disease. In theory, to diagnose a disease such as 
Alzheimer’s disease, EVs would be collected from patient CSF and analyzed for 
specific pathogenic markers, such as amyloid-β protein (Rajendran et al. 2006; 
Saman et al. 2012; Tapiola et al. 2009). This would allow doctors to more 
accurately diagnose patients at an earlier stage and thus offering any early 
treatment that may be vital to slowing the onset of the disease. However, many 
obstacles must be overcome before EVs can indeed be used as biomarkers of 
disease. To properly profile EVs, regardless of cell of origin, a pure sample of EVs 
must be isolated from the biological sample (Thind and Wilson 2016). Different 
methods have been described, but currently there is no universal standard for EV 
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isolation. Additionally, EVs released by cancer cells will inevitably carry cargo 
similar to non-cancerous cells thus making cancer EV detection seemingly 
complex (Thind and Wilson 2016). However, utilizing specific combinations of 
cargo as a unique molecular barcode, cancer EVs likely can be separated from 
other non-cancerous EVs. This approach has limitations. While some cancers 
might have similar molecular barcodes between patients, in some cases it is not 
unreasonable to speculate that EV cargo might be patient specific. Nevertheless, 
the more data acquired of cancer EVs and their cargo, the more likely these EVs 
will be of broader use as biomarkers of disease. 
 EVs have also been investigated as a therapeutic. EVs, with the exception 
of exomeres, are derived from the cell membrane and therefore have a lipid bilayer 
structure. Due to this structure, contents encapsulated within EVs are protected 
from RNases and proteases (Weber et al. 2010; Babu et al. 2011). In fact, EV 
miRNAs have remain stable at -20ºC for five years (Koga et al. 2011). EVs can be 
engineered to carry miRNA and mRNA and elicit transcriptional and proteomic 
regulation in target cells (EL Andaloussi et al. 2013; Bolukbasi et al. 2012; 
Wahlgren et al. 2012; Alvarez-Erviti et al. 2011; Maguire et al. 2012). Additionally, 
EVs can be targeted to specific cells via ligand-receptor modification or by direct 
transplantation into target tissue (Ohno et al. 2013). Finally, in terms of 
pharmaceutical therapy, EVs offer a more specific and direct method of drug 
delivery potentially resulting in better over-all effectiveness of the drug and 
reduction of cost (EL Andaloussi et al. 2013). Many studies have already 
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investigated the use of EVs as nano-therapy units. For example, RAD51, a 
eukaryotic DNA repair protein, was sufficiently knocked down in vitro through the 
delivery of an EV-loaded siRNA, and another in vivo study demonstrated EV 
targeting of neuronal cells after intravenous transplantation (Shtam et al. 2013; 
Ohno et al. 2013). While further research, including clinical trials, is needed, EVs 
prove to be a promising tool for medical technology. 
Brief Overview of Subventricular Zone (SVZ) Neural Development & 
Neurovesicles in Brain Development (Morton and Feliciano 2016): 
The subventricular zone (SVZ) is one of two neurogenic niches in the adult 
mammalian brain (Lim and Alvarez-Buylla 2016). During early embryonic gestation 
(embryonic day 8.5-10, E8.5-10), neuroepithelial stem cells (NESCs) line the wall 
of the ventricles, unlike that of the adult SVZ in which ependymal cells make up 
the ventricular wall (Taverna, Götz, and Huttner 2014). NESCs project a primary 
cilium and microvilli into the CSF filled ventricle (Dubreuil et al. 2007; Marzesco et 
al. 2005). The primary cilium has the ability to sense mitogenic and morphogenic 
cues, such as Sonic Hedgehog (SHH), from the CSF through receptors on the 
cilium itself (Corbit et al. 2005; Guemez-Gamboa, Coufal, and Gleeson 2014). 
NESC’s primary cilium contains prominin-1 (CD133), a stem cell marker protein 
(Dubreuil et al. 2007; Marzesco et al. 2005). Vesicles containing CD133 are 
released from NESC microvilli, cilium and the midbody during NESC division 
(Figure 2A) (Marzesco et al. 2005; Dubreuil et al. 2007). Interestingly, the number 
of CD133 decreased after E12 in both mouse and chick models of development 
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(Marzesco et al. 2005; Dubreuil et al. 2007). It is unclear as to the purpose of the 
release of CD133 positive particles from NESCs, but it could potentially be a 
method to remove cues from the cells themselves.  
At approximately embryonic day 11 (E11) in mice, NESCs give rise to 
choroid plexus epithelial cells (CPEs) and Radial glia (RG; Figure 2B) ( Lun, 
Monuki, and Lehtinen 2015; Taverna, Götz, and Huttner 2014). CPEs are located 
in the four ventricles in the brain and generate CSF. The ventricular system, 
comprised of interstitial fluid and CSF, is the nutrient delivery and waste disposal 
system that bathes the brain throughout life (Lun, Monuki, and Lehtinen 2015; 
Lehtinen and Walsh 2011; Damkier, Brown, and Praetorius 2013; Nedergaard 
2013). EVs have been identified in the CSF (Grapp et al. 2013; Akers et al. 2015; 
Bachy, Kozyraki, and Wassef 2008; Chiasserini et al. 2014; Marzesco et al. 2005; 
Dubreuil et al. 2007; Feliciano et al. 2014; Fraser et al. 2013; Akers et al. 2013; 
Harrington et al. 2009; Huttner et al. 2008; Saman et al. 2012; Street et al. 2012; 
Tietje et al. 2014; L. J. Vella et al. 2008; Yuyama et al. 2015). Since CPEs generate 
CSF and CSF contains EVs, it is likely that a portion of CSF-EVs originate from 
CPE (Figure 2B). Primary cultures of CPEs produce EVs that contain EV marker 
proteins including CD63, hnRNPA2/B1 and folate receptor (Grapp et al. 2013; 
Tietje et al. 2014). Other studies have identified morphogens and growth factors 
released by CPEs that regulate neurogenesis. One study in particular 
demonstrated that Insulin-like growth factor 2 (IGF2) is released by the choroid 
plexus and induces NSC proliferation(Lehtinen et al. 2011). In vitro studies of CSF-
14 
EVs show that CSF-EVs can modulate NSC behavior thus CPE EVs may regulate 
brain development (Feliciano et al. 2014). CSF EVs also undergo an age-
dependent decline, suggesting a more neurogenic role of CSF EVs than a 
modulator of homeostasis (Tietje et al. 2014). Indeed, loss-of-function mutations 
in CHMP1A was shown to cause microcephaly in patients through the reduction of 
exosome biogenesis and exosome mediated sonic hedgehog (SHH) release 
during neurogenesis (Coulter et al. 2018). 
RG reside at the latero-ventricular interface of the developing cortex 
(Taverna, Götz, and Huttner 2014). RG have a distinct morphology with an apical 
process that projects towards the lateral ventricle and through a primary cilium 
interact with the CSF, and a basal projecting process that anchors at the pial 
surface (Higginbotham et al. 2013; Noctor et al. 2001). Beginning at embryonic 
day 12 (E12) to E18-19 RGs first symmetrically divide to generate a progenitor 
pool, and then asymmetrically divide to give rise to neuroblasts (NBs). NBs initially 
exhibit a multipolar morphology, but transitions into a bipolar phenotype (Kriegstein 
and Noctor 2004). Using the basal projecting process as a scaffold, NBs migrate 
out radially to generate the excitatory glutamatergic pyramidal neurons of the 
laminar structured mammalian cortex in an inside-out fashion (Kriegstein and 
Noctor 2004; Taverna, Götz, and Huttner 2014). Interestingly, during spinal cord 
neurogenesis in the chick embryo, when NBs delaminate from the ventricular 
surface, they abscise a portion of their apical luminal projecting primary cilium 
(Figure 2D) (Das and Storey 2014). This particle is then left behind in the ventricle, 
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thus begging the question as to whether or not 1) this abscission product functions 
in intercellular signaling and 2) could apical abscission also occur for NBs 
produced by radial glia in the developing cortex.  
 Neurogenesis persists in the postnatal SVZ. NSCs in the SVZ arise from 
RGs (Figure 2G; Merkle et al. 2004). During early perinatal development, one 
population of SVZ NSCs undergo self-renewal symmetric divisions (Obernier et al. 
2018). Whereas a separate, larger population of SVZ NSCs give rise to Type C 
cells that divide three or four times to generate NBs which migrate along the rostral 
migratory stream to the olfactory bulb (OB) where they differentiate into 
periglomerular or granule interneurons (Bjornsson et al. 2015; Luskin 1993; Lois, 
Garc a-Verdugo, and Alvarez-Buylla 1996; Petreanu and Alvarez-Buylla 2002; 
Imayoshi et al. 2008). SVZ NSCs continue to generate NBs destined for the OB 
until approximately postnatal day 15 (P15) when the SVZ begins to resemble that 
of an adult SVZ (Tramontin et al. 2003). SVZ NSCs also produce astrocytes, 
oligodendrocytes and ependyma cells (Figure 2F). Astrocytes and 
oligodendrocytes are considered the support cells of the brain, and ependyma cells 
line the ventricular interface and generate a cellular barrier between the CSF and 
the SVZ (Bjornsson et al. 2015; Mirzadeh et al. 2008). Both astrocytes and 
oligodendrocytes generate EVs for which the developmental impact has only 
begun to emerge (Figure 2F) (Bianco et al. 2009; Gosselin, Meylan, and 
Decosterd 2013; Wang et al. 2011; Proia et al. 2008; Frühbeis et al. 2013). SVZ 
NSCs have a bipolar morphology, similar to RG. SVZ NSCs project an apical 
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process through a pinwheel structure of ependyma cells to contact the ventricle 
(Mirzadeh et al. 2008). This apical process also contains a primary cilium that 
interact with the CSF (Mirzadeh et al. 2008).  Additionally, SVZ NSCs project a 
basal process onto a nearby blood vessel where they interact with pericytes on 
endothelial cells to regulate blood flow (Lacar et al. 2012). Unlike RG, SVZ NSCs 
have been shown to release EVs in vitro (Figure 2G). For instance, SVZ NSC EVs 
were shown to be taken up by NIH3T3 cells, and through EV-associated interferon 
gamma (IFN-γ) and interferon gamma receptor-1 (Ifngr1) complexes, activated 
Stat1 signaling in target cells (Cossetti et al. 2014). Another study demonstrated 
that EVs released from SVZ NSCs in vitro were selectively targeted to taken by 
microglia  in vivo resulting in a transcriptional and cytokine profile alteration in the 
resident microglia (Morton et al. 2018). When transplanted into the lateral 
ventricles of P0 mice, microglia conditioned media, after treatment and depletion 
of EVs, resulted in reduction of SVZ NSC proliferation (Morton et al. 2018). While 
it is clear that EVs are prevalent during SVZ neurogenesis, it is still unclear how 
EVs contribute to the establishment of complex circuitry and structure in brain 
development. 
Conclusions: 
From development to disease, EVs play a substantial role. Understanding 
EV biology will allow for advances in not only our understanding of development, 
but also medical biomarkers and therapeutics. To understand the complexity of 
EVs, future studies will be required to parse apart EV sources, targets and 
17 
 
functions. EV studies continue to push the limit of scientific technology. As 
researchers investigate these nanometer sized particles, better and more precise 
technology must be established to more accurately study EVs. From garbage 
disposals to molecular messengers, EVs have altered the current understandings 
of intercellular communication. 
Dissertation Goals and Objectives 
 The goal of this dissertation is to determine if EVs are released from early 
postnatal SVZ NSCs and their physiological function. Previous studies have found 
an abundance of EVs within embryonic and adult CSF, but the sources, targets 
and functions are unclear. SVZ NSCs line the latero-ventricular wall during 
neonatal neurogenesis and interact with CSF. Therefore, SVZ NSCs were a 
potential source of CSF EVs. I hypothesized that SVZ NSCs release EVs carrying 
specific molecular cargo and are taken up and regulate target cells.  This 
dissertation provided three objectives: 
 
Objective 1: Generate an experimental paradigm to study the effects of 
primary SVZ NSC EVs in vivo. We constructd a protocol specific to the culturing 
of primary SVZ NSCS, isolation of EVs and subsequent transplantation of labeled 
EVs in vivo.  
 
Objective 2: Analyze and assess the uptake of SVZ NSC EVs in target cells. 
Using the protocol established in the first objective, we assessed the uptake of 
18 
SVZ NSC EVs in vivo in target cells largely through next-generation RNA 
sequencing, western blotting, immunohistochemistry, Luminex assays and 
transplantation experiments.  
Objective 3: Generate an in vivo model system to label and study EVs. Since 
EV experimentation is limited by available scientific tools, we generated a 
transgenic mouse model system to fluorescently label and track tetraspanin CD9-
containing vesicles in a temporally and spatially regulated manner. This model 
system was used to validate the generation of SVZ NSC EVs in vivo.  
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Figure 1. 
 Schematic of Extracellular Vesicle Release and Exosome Uptake. A-B) Cell 
membrane invaginates to generate an early endosome. C) The early endosome 
undergoes further inward budding to generate a multivesicular body (MVB) 
encapsulating intraluminal vesicles. EV marker proteins (red, green, blue and 
pink) and miRNA (purple) are found integrated into the lipid bilayer and inside of 
the vesicles, respectively. D) MVB then fuses with the cell membrane and 
exosome are released into the extracellular space. Exosomes are taken up by 
target cells in multiple ways. E) Exosomes can fuse with the cell membrane 
releasing its molecular contents into the target cell. For instance, exosomal 
miRNA can be released into the recipient cell and target specific mRNA (F). 
Conversely, exosomes can be taken up through endocytic pathways (G). Finally, 
microvesicles are generated through the outward budding the cell membrane (H).  
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Figure 2.  
Schematic of Extracellular Vesicles and Cortical Development. A) During 
formation of the neural tube at embryonic day eight (E8), invagination of the 
epithelium results in neuroepithelial stem cells (NESCs) that orient their apical 
surface toward the lumen of the neural tube. NESCs contain CD133 on the 
ventricular projecting primary cilia, mid-body, and microvilli. NESCs release 
CD133 positive large ~600 nm, (P2 fraction; pink) and 50–80 nm (P4 
fraction; blue) vesicles into the lumen of the neural tube. B) NESCs produce 
choroid plexus epithelial cells (CPEs) beginning at E11−12. Cultured CPEs 
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release extracellular vesicles including microvesicles (MV, green). C At E11−12, 
radial glia are generated from NESCs, and span the developing cortex, beginning 
at the ventricular surface and extending a radial process to the pial surface. It is 
unknown whether EVs are released from radial glia. D) Radial glia undergo 
asymmetric division and give rise to immature glutamatergic neurons, called 
neuroblasts, that migrate into and populate the cortical plate. Through a similar 
process, neuroblasts that are produced in the developing chick embryo 
delaminate from the ventricular surface and release a particle into the ventricle 
during apical abscission (Apical Abscission Particle; purple). E) Once 
neuroblasts mature into neurons, excitatory stimuli such as glutamate and 
depolarization can induce the release of microvesicles (green) and exosomes 
(red) that may target astrocytes while others target neurons. Oligodendrocytes 
that myelinate the axons of neurons also release EVs in response to 
glutamate. F) NESCs eventually give rise to astrocytes which release EVs that 
target neurons. As with oligodendrocyte EVs, those from astrocytes seem to be 
neurotrophic. G) NSCs that persist in the subventricular zone (SVZ) are 
contiguous with the lateral ventricles. SVZ NSCs generate both exosomes (red) 
and microvesicles (green; Morton and Feliciano 2016). 
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CHAPTER TWO 
Isolation of Extracellular Vesicles from Subventricular Zone Neural Stem Cells. 
 
 
A version of this manuscript was published in Methods in Molecular Biology and is 
in the format required of that journal. The citation for the published manuscript is: 
 
Morton, M.C., Neckles, V.N. and Feliciano, D.M. (2018). Isolation of Extracellular 
Vesicles from Subventricular Zone Neural Stem Cells. Methods in Molecular 
Biology. Humana Press. 
ABSTRACT  
The neonatal subventricular zone (SVZ) is a neurogenic niche that contains neural 
stem cells (NSCs). Extracellular vesicles (EVs) are released from many cell types. 
EVs encapsulate a wide array of biological material including nucleic acids. EVs 
are proposed to be targeted to recipient cells.  Recent studies have demonstrated 
that SVZ NSCs release EVs. A classic developmental approach to uncovering bio-
activity of molecules is to perform in vivo transplantations. Here we demonstrate 
how to culture neonatal SVZ NSCs and to isolate and subsequently transplant EVs 
into the neonatal brain. Using this approach, we demonstrate that NSC EVs label 
microglia. 
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INTRODUCTION   
Extracellular vesicles (EVs) are membranous derived particles that range in 
size from 50 – 500nm, and are categorized by their mechanism of biogenesis 
(Cocucci and Meldolesi 2015). First, exosomes are derived from multivesicular 
bodies (MVBs) which fuse with the cellular membrane to release the vesicles from 
the cell (Théry, Zitvogel, and Amigorena 2002). Conversely, microvesicles are 
produced through the outward budding of the cell membrane (Théry, Zitvogel, and 
Amigorena 2002). Finally, a new species of non-membranous EVs has recently 
been identified called exomeres (Zhang et al. 2018). EVs are thought to modulate 
intercellular communication through the transfer of biological material, such as 
mRNA, miRNA, and protein from donor to recipient cells (Ramachandran and 
Palanisamy 2012; Valadi et al. 2007). For example, EVs have been shown to 
activate viral-sensing receptors, such as Toll-like receptors (TLRs) and RIG-1 in 
recipient cells (Eckard et al. 2014). Additionally, other reports have discovered the 
transfer of biologically active proteins, such as asparaginase (Iraci et al. 2017).   
Various methodologies have been used for isolating EVs. Polymer-based 
isolation utilizes polyethylene glycol to isolate a high yield of EVs (Momen-Heravi 
et al. 2015), but is limited in purity of EVs due to lipoprotein contaminants (Vickers 
et al. 2011; Lobb et al. 2015). Additionally, other studies have employed 
ultracentrifugation to isolate a “dirty” EV pellet, but inconsistencies with 
reproducibility have been reported (Livshits et al. 2015; Bobrie et al. 2012). Some 
methods call for a clean-up step to further purify exosomes following 
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ultracentrifugation. EVs pellets are resuspended in high molarity (M) sucrose, and 
then sucrose of decreasing M are layered on top.  It is recommended that the 
finished gradient containing EVs is centrifuged at a very high speed for at least 16 
hrs to ensure proper EV sedimentation (Taylor and Shah 2015). Sucrose density 
gradient fractionation relies on the density of EVs for isolation. Exosomes are 
collected from fractions at a sucrose concentration of 1.1 – 1.9 g/mL, but other 
studies have discovered that, depending on the density, EVs overlap and are not 
separated completely (Taylor and Shah 2015; Théry et al. 2006). Sucrose density 
gradients have their own limitations including structural compromise, EV fusion, 
and vesicle rupture (Linares et al. 2015). Currently, there is no universal standard 
for EV isolation.  
The subventricular zone (SVZ) is one of two neurogenic niches in the 
perinatal brain (Lim and Alvarez-Buylla 2016). Located contiguous with the lateral 
ventricles, one population of SVZ neural stem cells (NSCs) symmetrically divide to 
as mode of self-renewal (Obernier et al. 2018). Whereas a separate, larger 
population of NSCs give rise to Type C cells that divide three or four times to 
generate neuroblasts which migrate along the rostral migratory stream to the 
olfactory bulb where they differentiate into periglomerular or granule interneurons 
(Bjornsson et al. 2015; Luskin 1993; Lois, Garc a-Verdugo, and Alvarez-Buylla 
1996; Petreanu and Alvarez-Buylla 2002; Imayoshi et al. 2008). Reduction in the 
number of SVZ NSCs occurs in correlation in both aging and in continued NSC 
proliferation (Bouab et al. 2011; Daynac et al. 2016). Additionally, the number of 
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SVZ NSCs decrease by ~60% between early postnatal life (0-7 days) and adults 
at 26 months (Maslov et al. 2004). Interestingly, the neurogenic zone in the SVZ 
decrease significantly between 0 and 15 days postnatally (P0 – P15), and at P15, 
the SVZ begins to resemble that of an adult SVZ (Tramontin et al. 2003). SVZ 
NSCs produce astrocytes and oligodendrocytes, the support cells of the nervous 
system (Bjornsson et al. 2015), and ependyma cells that act as a barrier between 
the SVZ and the fluid-filled lateral ventricles (Mirzadeh et al. 2008). The early 
perinatal SVZ (P0-P1) is comprised mainly of NSCs. Resident central nervous 
system (CNS) immune cells infiltrate the developing nervous system from the yolk 
sac at embryonic day 8.5-9.5 (Ginhoux et al. 2010). These cells, called microglia, 
congregate in proliferative zones in the perinatal brain, that later in postnatal 
development migrate out to and populate the cortex (Cunningham, Martínez-
Cerdeño, and Noctor 2013; Swinnen et al. 2013). Microglia release factors that 
regulate NSC proliferation during embryonic development and into perinatal 
neurogenesis (Battista et al. 2006; Zhu et al. 2008; Antony et al. 2011; Snyder et 
al. 1997). Recent studies have identified SVZ-NSCs as sources of EVs that 
regulate neighboring cells, including microglia (Morton et al. 2018; Cossetti et al. 
2014; Asai et al. 2015).  
When culturing primary SVZ NSCs, various methodologies have been 
described in which their utility is dependent on the goal of the experiment. Primary 
SVZ NSCs have been cultured through neurosphere assays (Reynolds and Weiss 
1996), adherent monolayer systems (Ray, Raymon, and Gage 1995; Palmer, Ray, 
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and Gage 1995), and matrixgels. Neurosphere assays allow for the examination 
of differences in cell proliferation and cell potential (Walker and Kempermann 
2014). Neurospheres themselves are heterogenous clusters of NSCs, progenitor 
cells, and differentiated cells (Suslov et al. 2002; Parmar et al. 2003) that, together, 
generate a stem cell niche with more differentiated cells residing in the center 
(Azari et al. 2010; Bez et al. 2003). Unlike neurosphere culturing, adherent 
monolayer systems more closely recapitulate in vivo proliferation and have a more 
homogenous population of NSCs (Walker and Kempermann 2014; Babu et al. 
2011). The homogeneity of adherent monolayer systems allow for a better 
interpretation of NSCs rather than NSC niches of neurospheres. Finally, matrixgels 
are used to construct a 3D structure that mimics the extracellular matrix in which 
NSCs reside in vivo (Aligholi et al. 2016). Different from non-adherent cell culture 
systems, such as neurospheres, cells cultured in matrixgels have a distinct 
advantage in that they are cultured in a degradable biomaterial which provides 
structural integrity (Thonhoff et al. 2008). Matrixgel culturing systems are an 
important avenue of culturing methodologies, specifically in terms of neuro-
regeneration in vivo (Thonhoff et al. 2008; Moradi et al. 2012).  
Here we demonstrate in detail the culturing of the neonatal SVZ, which is 
enriched in NSCs (Walker and Kempermann 2014) the isolation of NSCs EV with 
the production of a “dirty” fraction and a subsequent clean-up step, followed by the 
labeling and transplantation of EVs into the developing perinatal lateral ventricles.  
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MATERIALS   
1. Primary Cell Culture and Microdissection 
a. Mouse Laminin  
b. Neurobasal A Complete Culture Media: Neurobasal A Medium, 2% 
B27, 1X Glutamax, 50 units/mL Penicillin/Streptomycin, 20 ng/mL 
purified mouse receptor-grade epidermal growth factor (EGF) and 20 
ng/mL recombinant bovine fibroblast growth factor (FGF-2). 
c. Disassociation Buffer: 0.05% Trypsin-EDTA, Neurobasal A Medium 
d. Cascade Biologicals Trypsin Inhibitor  
e. Sterile Microdissection Kit  
f. Scalpel 
2. Sucrose Density Gradient Exosome Isolations 
a. Thickwall Polycarbonate Tube or Ultracentrifuge Tubes 
b. Sucrose for Density Gradient: 2.5M Sucrose, 1X d-Phosphate 
Buffered Saline Solution (dPBS) 
c. Beckman Coulter Optima MAX-XP centrifuge with TLA 100.3 rotor. 
3. Exosome Labeling and Transplantation 
a. Vibrant DiI Cell-Labeling Solution. 
b. 10 cm fire polished borosilicate glass capillary tubes or Hamilton 
Neuros Syringe. 
c. Table-top centrifuge. 
 
53 
 
PROTOCOL  
1. Preparation of Culture Medium 
1.1. 24 h prior to culturing SVZ NSCs, prepare Laminin-coated wells for 
adherent monolayer NSC cultures. To prepare culture wells, add 8.5 
ug/mL in DiH2O per well and incubate at 37°C overnight. Wash wells 
three times using DiH2O and use wells immediately.  
1.2. Prepare fresh culture media on the day of dissections by mixing 
Neurobasal A Medium with 2% B27, 1X Glutamax, 50 units/mL 
Penicillin/Streptomycin, 20 ng/mL purified mouse receptor-grade 
epidermal growth factor (EGF) and 20 ng/mL recombinant bovine 
fibroblast growth factor (FGF-2). Warm culture media to 37°C. (see Note 
1) 
1.3. Prepare glass Pasteur pipettes with varying hole sizes by rotating tip 
of glass pipette over an open flame until desired hole size is obtained. 
Ideally a “small,” “medium,” and “large” hole are best suited for culturing. 
(see Note 2) 
1.4. Prepare 0.05% Trypsin-EDTA in Neurobasal A for the Disassociation 
Buffer, and 1X Trypsin Inhibitor (Cascade Biologicals). Pre-warm to 
37°C. 
1.5. Sterilize dissection tools (forceps x2, microdissection scissors, 
dissection scissors, dissecting microscope, scalpel). (see Note 3) 
2.  Harvesting perinatal brains and SVZ microdissections 
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2.1. Anesthetize P0 – P1 pup by placing it on ice for 5 minutes or by 
following the facility’s proper guidelines.  
2.2.  Decapitate pup using scissors and carefully remove the skull by 
cutting between the two hemispheres and using forceps to peel back 
the skin and skull thus exposing the brain. (see Note 4) 
2.3. Carefully remove the brain by using the curved or soft edges of the 
forceps and place it on ice-cold 1X Phosphate Buffered Saline (PBS) 
solution under the dissecting scope with the ventral side up.  
2.4.  Using the scalpel, remove any remaining olfactory bulbs. Then make 
a single coronal section 1/3 of the distance from the most rostral 
portion of the cortex, severing the cortex into two pieces. Discard the 
most caudal piece. 
2.5. To microdissect the SVZ place the rostral portion of the cortex with 
the cut side facing up. Carefully tease apart the SVZ from the cortex 
at the lateral ventricle walls and place dissected SVZ into Neurobasal 
A incubated on ice. For further reference, please see Walker and 
Kemperman, 2014 13. 
3.  SVZ Tissue Dissociation 
3.1. Place dissected SVZ into 750 µL Disassociation Buffer (0.05% 
Trypsin-EDTA in Neurobasal A), gently invert the sample two or three 
times and incubate at 37°C for 7 min. 
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3.2. Add 1:1 ratio of 1 X Cascade Biologicals Trypsin Inhibitor to 
Disassociation Buffer and centrifuge for 5 min at 300 x g in Eppendorf 
Centrifuge 5415 D. 
3.3. Aspirate supernatant and re-suspend cell pellet in 1000 µL pre-
warmed Neurobasal A Complete Media 
3.4.  Using fire polished glass pipettes, triturate cells. Starting with the 
pipette with the “large” hole and moving to the pipette with the “small” 
hole. (see Note 5) 
3.5. Spin down cells for 5 min at 300 x g, and re-suspend in 200 µL and 
plate cells at 1 x 106 cells/mL. 
3.6.  Place cells in 37 ℃   incubator with 5% CO2. Do not disturb cells for 
at least 24 hours. After 24 h, replace half of the media. (see Note 6) 
4. Exosome Isolation from SVZ NSC Culture Media using Sucrose Density 
Gradients 
4.1.  Prepare 2.5 M sucrose in 1 X dPBS immediately prior to exosome 
isolation. Dilute 2.5 M sucrose to 2.0 M, 1.5 M, 1.0 M, 0.5 M and 0.25 
M. (see Note 7) 
 
4.2. 48 hr after SVZ NSC culture initiation, collect culture media and begin 
exosome isolations. Centrifuge media for 10 min at 300 x g and then 
10 min at 2000 x g in an IEC Centra GP8 centrifuge. (see Note 8) 
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4.3. Dispense media into ultracentrifuge tubes. Ultracentrifuge tubes 
should be equal in weight to prevent unequal weight distribution in 
the rotor. (see Note 9) 
4.4. Centrifuge exosome containing media for 90 min at 100,000 x g at 4 
°C in Beckman Coulter Optima MAX-XP centrifuge with TLA 100.3 
rotor. This will result in a pellet hereon referred to as the P100 pellet. 
(see Note 10)  
4.5. Resuspend the P100 fraction in 2.5 M sucrose and layer the other 
sucrose solution in descending order (2.0 M, 1.5 M, 1.0 M etc.). Take 
extra caution not to disturb any layer otherwise the gradient will not 
form properly. Weigh the completed sucrose gradients and ensure 
equal weight before moving on to the next centrifuge step. (see Note 
11) 
4.6. Place gradients in ultracentrifuge rotor and place the rotor in the 
ultracentrifuge. Spin gradient for 18 h at 4°C at 100,000 x g. 
4.7. Discard top layer and collect ten (1-10), equal fractions and place 
each fraction in a separate ultracentrifuge tube. Dilute 1:10 in 1 X 
dPBS and spin each fraction for 1 h at 100,000 x g at 4°C. (see Note 
12) 
4.8. Discard supernatant and resuspend each fraction in 30 µL 1 X dPBS. 
Collect exosome fractions 5 – 8. Exosomes can be stored at -20°C 
or immediately labeled and used for transplantation. (see Note 13) 
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5. DiI Labeling of Exosomes and Transplantation  
5.1.  Centrifuge exosomes at 14,000 x g for 30 min or at 100,000 x g for 
1 hr.  
5.2. From a 1 mM stock solution of DiI labeling solution, resuspend pellets 
in 1 µM DiI labeling solution in 1 X dPBS and incubate fractions for 
10 min at room temperature and vortex periodically during 
incubation.  
5.3. Centrifuge fractions at 14,000 x g for 30 min at Room Temperature. 
5.4. Resuspend fractions in 1 X PBS and repeat steps 5.2. – 5.3. 3x 
times. (see Note 14) 
5.5. Resuspend final pellet of DiI labeled exosomes in 50 µL 1 X dPBS 
and either store exosomes at -20 °C or move immediately to 
transplantation. 
6. Transplantation of exosomes into lateral ventricle of P0 pups. 
6.1. Prior to transplantations, prepare pulled glass pipettes by placing 10 
cm fire polished borosilicate glass capillary tubes (O.D.: 1.5mm, I.D.: 
1.1mm) into a Sutter Instrument Company Model P-97 pipette puller. 
Place pipettes in a sterile container for transplantations. 
Alternatively, a Hamilton Neuros Syringe can also be used for 
injections.  
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6.2. Using an aspirator connected to the capillary tube or a Hamilton 
Neuros Syringe constructed with a Neuros Adapter, load 1-2 µL of 
DiI labeled exosomes. 
6.3. Anesthetize P0 pup on ice for 5 min or until pup slows down. Hold 
pup in between thumb, index and middle finger (nose should be 
anchored using thumb). Pull skin back to identify injection site. 
6.4.  Identify midline of the brain. Place capillary needle or Hamilton 
Neuros Syringe needle near the rostral portion of the brain at the 
midline. Move the needle approximately 1 mm laterally in either 
direction and 0.5 mm caudally and insert needle into the lateral 
ventricle approximately 2 mm deep. Inject 1-2 µL DiI labeled 
exosomes into the lateral ventricles. 
6.5.  Place pups on heating pad briefly and put back with mother. Sacrifice 
pups 24 or 48 h after transplantation, collect and fix brain and begin 
immunohistochemistry.  
Notes: 
1. Neurobasal A Complete Media can be stored at 4°C for two weeks. 
It is recommended that fresh Complete Media be made for this 
protocol.  
2. It is recommended that three glass 58asteur pipettes with varying 
hole sizes should be prepared each with decreasing bore size. 
Before using on SVZ tissue, be sure that liquid can pass through the 
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newly sized hole.   
3. All tools should be sterilized prior to tissue dissection. Primary 
cultured cells are extremely susceptible to contamination. Any steps 
involving the dissected tissue should be completed under a cell 
culture hood using 70% Ethanol to sterilize when appropriate.  
4. When removing the brain, be sure to not cut too deep between the 
hemispheres or use the sharp edges of the dissection forceps to 
remove the skull. Either could result in puncturing the brain and 
damaging the tissue.  
5. Media should have a cloudy appearance indicating proper tissue 
dissociation. Do not triturate cells excessively. 7-10 times total is 
more than sufficient.  
6. Save media. Do not discard. 
7. For each exosome isolation procedure, be sure to prepare fresh 
2.5M Sucrose solution in 1X dPBS. 
8. Transfer media into a new tubes in between centrifugation steps. Be 
sure to not disturb the pellet.  
9. When weighing the ultracentrifuge tubes, the tubes should be equal 
in weight to the 100th decimal place to prevent systemic mechanical 
breakdown.  
10. Prior to ultracentrifugation, ensure tubes plus the sample are equal 
in weight to the 100th decimal place. Additionally, P100 fractions can 
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be used for postnatal transplantations. P100 fraction contains both 
exosomes and microvesicles.  
11. In some cases a syringe is most useful to construct the sucrose 
gradient layers. When constructing the sucrose density gradient, do 
not add the next layer of sucrose directly onto the previous layer in a 
destructive manner. Instead, pipet each layer of sucrose down the 
side of the tube, gently, to ensure that the prior layer is not disrupted. 
Again, weigh each tube containing the sucrose gradients and 
equilibrate using 1X dPBS. 
12. When collecting fractions, collect from the top down. Be careful not 
to insert the pipet tip too far into the gradient, thus disrupting lower 
layers. 
13. Exosome pellets can appear as a gray or translucent pellet. Take 
note of tube orientation in the rotor before resuspending pellet. 
14. To ensure no DiI labeling particles are left in the exosome pellet, 
repeat the washes in 1x dPBS as many times as needed. 
DISCUSSION  
Here we have demonstrated the transplantation of SVZ NSC EVs from 
primary cultures to in vivo perinatal lateral ventricles. Transplantation experiments 
have been widely used in the field of developmental biology, and continue to be 
implemented today; however, transplantation experiments have their limitations.  
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In this study, EVs from primary cultures of SVZ NSCs were isolated, 
labeled, and transplanted into the lateral ventricles of perinatal mice. One limitation 
to this technique is the use of primary SVZ NSCs culture as the source of EVs and 
not SVZ NSCs in vivo. To circumvent this caveat, an in vivo EV labeling system 
would need to be generated to capture and isolate EVs directly from in vivo 
sources. Additionally, cultured SVZ NSCs are highly susceptible to contamination. 
Contamination would result in alterations to the EV profile of primary SVZ NSCs, 
therefore special precaution should be taken to ensure sterilization of all tools, 
solutions, and tubes. Furthermore, this methodology of SVZ NSC isolation yielded 
a high percentage of cells that stained positive for the NSC marker Nestin, however 
without selectively isolating NSCs, via differential centrifugation or flow cytometry, 
it is likely that the primary cultures were a mixed population of SVZ cells. Although 
none of the cells stained positive for the neuroblast marker Doublecortin (DCX), 
NSCs in transition from a stem cell to an astrocyte, for example, are likely to stain 
positive for both the NSC marker Nestin and the Astrocyte marker GFAP  
(Tramontin et al. 2003; Bouab et al. 2011; Petreanu and Alvarez-Buylla 2002; 
Mirzadeh et al. 2008). Further purification of NSCs should be explored to ensure 
a pure population of NSC EVs.  
While most studies report a high abundance of EV release from cells, the 
amount of miRNA and mRNA contained within these EVs remains under scrutiny 
(Morton and Feliciano 2016; Morton et al. 2018; Cossetti et al. 2014; Chevillet et 
al. 2014). One study reported that for every 100 EVs, only one contained miRNA 
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(Chevillet et al. 2014). If this is the case, in vivo EV function may only require a 
very low abundance of miRNA to be present, thus transplantation experiments may 
not recapitulate in vivo conditions. In order to address this issue, the rate of release 
from SVZ NSCs would need to be taken into consideration. If transplantation 
experiments elevate EV numbers by 108 per mL, then any biological response may 
only be superfluous (Morton et al. 2018). EVs might stimulate a cellular response 
in neighboring cells for which this occurrence is 1 in 100, so introducing an 
abundance of EVs might result in a cellular response above endogenous levels. 
Additionally, sucrose density gradients can result in vesicle disruption or fusion 
(Linares et al. 2015). The phenomenon would likely alter the profile of EVs 
collected and biological data (miRNA, RNA, and protein) might be lost or disrupted. 
To avoid this issue, P100 fractions of EVs can be used for transplantations, 
although other studies have identified molecular contaminates within this fraction 
(Livshits et al. 2015; Bobrie et al. 2012). Going forward, alternate methods of EV 
isolation should be taken into consideration, such as size exclusion, FACS or 
immunocapture. 
The field of EVs has rapidly expanded in the past 10 years. Thus 
nomenclature, isolation techniques, and characterization of these vesicles are still 
undergoing constant reconstruction. EVs are thought to modulate intercellular 
communication through the transfer of miRNA, RNA, and protein, and furthermore, 
each EV contains its own unique molecular bar code. This begs the question, what 
information can be transferred between cells or organisms? Could EVs carry 
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molecular information pertaining to consciousness or memories? As the field 
continues to expand, more precise techniques will need to be employed to answer 
these questions.  
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FIGURES:  
Figure 1. Isolation and Transplantation of EVs from SVZ NSCs. A) 
Schematic brain section highlighting regions dissected (purple). B) Following 
isolation, these cells were cultured as monolayers. Cells stained positive for the 
NSC marker Nestin (green). DNA was counterstained using TOPRO-3 (blue). 
C) The conditioned media was subjected to a serial centrifugation protocol that 
produces a “dirty fraction” that contains EVs (P100). These EVs were then 
further purified using a sucrose gradient. D) Isolated EVs were then labeled 
with DiI (red) and injected into the lateral ventricles of a P0 pup. E) Brains were 
harvested from P0-P7 mice and EVs (red) targeting cells were detected. 
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Labeled cells were Iba1 positive (blue) and CD11b positive (green). 
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ABSTRACT 
Subventricular Zone (SVZ) Neural Stem Cells (NCSs) persist in the perinatal 
neurogenic niche and give rise to neurons early and late into adulthood. Microglia 
are the immune cells of the central nervous system that help form the intricate 
neural circuitry of the mammalian brain. Extracellular vesicles (EVs) are cellular-
derived, nanometer-sized vesicles that encapsulate miRNA and proteins. It is 
thought that EVs transfer molecular information from donor to recipient cells which 
may play a role in normal development or could potentially contribute to the 
pathogenesis of disease. In this study, we tested the communicative potential of 
SVZ NSC EVs and microglia in the perinatal brain. Using a fluorescent fusion EV 
protein, CD9-GFP, to study EV release, it was found that SVZ NSCs generated 
EVs. The fusion protein was expressed in Nestin-positive NSCs in the SVZ and 
could be detected outside of labeled cells. Scavenging microglia selectively took 
up tagged NSC EVs. Small RNA sequencing identified miRNAs within NSC EVs 
that regulate microglia physiology and morphology. NSC EVs induced a transition 
of microglia to a non-stellate, rounded morphology. This morphological shift was 
accompanied by an altered microglial transcriptional state and cytokine profile 
which contributed to a negative feedback loop that controlled NSC proliferation. 
These data suggest that SVZ NSCs generate EVs that are targeted to and alter 
microglia within the perinatal brain. These finding offer insight into normal and 
pathophysiological functions of EVs during brain development.   
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INTRODUCTION 
Neural stem cells (NSCs) reside in discrete regions, called neurogenic 
zones, of the adult mammalian brain. In rodents, these NSCs produce neurons 
throughout life that populate the olfactory bulb and are imperative for olfactory 
sensation (Lledo and Valley 2016). The subventricular zone (SVZ) is one of two 
neurogenic zones in the adult mammalian brain (Lim and Alvarez-Buylla 2016). 
Intercellular communication is required for producing the proper number and types 
of cells in the SVZ (Choe, Pleasure, and Mira 2016). Alterations in SVZ 
environmental conditions or genetic signaling in SVZ NSCs likely generate certain 
tumors and malformations (Dietrich, Imitola, and Kesari 2008; Vescovi, Galli, and 
Reynolds 2006; Zhou et al. 2011). Thus, understanding mechanisms that regulate 
their development and maintenance is of upmost importance. 
Microglia are the primary immune cells of the nervous system. Interestingly, 
a population of microglia reside in the neonatal SVZ, and in adulthood, migrate out 
and become evenly distributed through the brain (Shigemoto-Mogami et al. 2014). 
Microglia are haematopoietically derived myeloid cells that originate from yolk sac 
macrophages (Ginhoux et al. 2010; Prinz, Erny, and Hagemeyer 2017). Using the 
developing vasculature, microglia migrate into the brain during mid-gestation and 
go on to produce a majority of the resident microglia during the first postnatal 
weeks (F Alliot et al. 1991; Francoise Alliot, Godin, and Pessac 1999). Microglia 
have been shown to influence neural progenitor cells (NPCs), and other studies 
have shown that NPCs likely influence microglia (Pluchino and Cossetti 2013; Sato 
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2015; Lehtinen and Walsh 2011; Su et al. 2014; Shigemoto-Mogami et al. 2014). 
One study in particular demonstrated the accumulation of activated microglia in 
the neonatal SVZ and the combinatorial effects of microglia released cytokines on 
NSC proliferation (Shigemoto-Mogami et al. 2014). This report alone provides 
evidence for a neuro-developmental role of microglia.   
Extracellular vesicles (EVs) are found in most biological fluids, including 
blood, urine, and cerebrospinal fluid (CSF) (Morton and Feliciano 2016; Feliciano 
et al. 2014). EVs are primarily membranous vesicles that range in size from 30-
500nm and have the capacity to carry an array of cargo, including miRNA, mRNA, 
and protein (Raposo and Stoorvogel 2013; Maas, Breakefield, and Weaver 2017). 
Three types of EVs have been documented: exomeres, exosomes, and 
microvesicles. Exomeres are non-membranous particles comprised of metabolic, 
translational, and coagulation regulating proteins (H. Zhang et al. 2018). Unlike 
other documented EVs, exomere biogenesis is not well understood (H. Zhang et 
al. 2018) Exosomes are produced when a multivesicular body fuses with the cell 
membrane (Théry, Zitvogel, and Amigorena 2002). Exosomes are distinct from 
other types of EVs in that they are less than 150nm in size and exhibit a cup-like 
morphology when viewed under electron microscopy (EM) (Théry, Zitvogel, and 
Amigorena 2002). Finally, microvesicles, the largest type of EV (200-500nm), are 
generated by the outward budding and scission of the cell membrane (Cocucci 
and Meldolesi 2015; Maas, Breakefield, and Weaver 2017). Recent studies have 
demonstrated that in vitro SVZ-derived NSCs/precursor cells release EVs. 
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(Cossetti et al. 2014). When used to treat NIH 3T3 cells, EVs isolated from cultures 
of primary SVZ NPCs activated Stat1 signaling in target cells (Cossetti et al. 2014). 
However, in vivo targets and functions of NSC EVs remain undetermined. 
In this study, we investigated whether SVZ NSCs produce EVs, and what 
the in vivo targets were. Primary cultures of neonatal SVZ NSCs were found to 
release EVs. Transplantation experiments revealed that NSC EVs were selectively 
taken up by microglia in the neonatal SVZ. EV uptake was observed in 
CD11b/Iba1-positive microglia with a distinct rounded cellular morphology. RNA 
sequencing and cytokine profiling of microglia treated with NSC exosomes showed 
a changed in the transcriptional network and cytokine profile. Alterations in the 
microglia cytokine profile resulted in a negative feedback loop determined by EdU 
labeling in SVZ NSCs in vivo.  
RESULTS 
Neonatal SVZ NSCs Release EVs 
Primary cultures of postnatal day zero (P0) SVZ NSCs cultured as a 
monolayer were subjected to immunocytochemistry and western blotting for the 
NSC marker protein Nestin. Most cells (~92%) were Nestin-positive (Figure 1A). 
Conversely, SVZ cultures were negative for the migrating neuroblast marker 
doublecortin (DCX; data not shown). Nestin could also be detected by western blot 
of primary SVZ NSC lysates. (Figure S1A) Neonatal SVZ NSC conditioned media 
was subjected to low-speed centrifugation to remove dead cells and cellular debris. 
To assess number and particle size present within the NSC conditioned media, 
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nanoparticle tracking analysis (NTA) was utilized. Four peaks were identified at 89, 
129, 199, and 263nm with an average size of 164.9±7.2nm. NSC conditioned 
media was also subjected to an ultracentrifugation protocol to further isolate EVs. 
Ultracentrifugation yielded an NSC P100 fraction and NTA revealed four peaks at 
109, 154, 209. and 312 with an average size of 190.7±5.2nm (Figure 1B). Electron 
microscopy confirmed the size of P100 EVs, and some EVs presented a cup-like 
morphology, characteristic of exosomes (Figure 1D).  
 Tetraspanin CD9 is frequently used as a protein marker of EVs (Raposo 
and Stoorvogel 2013; Andreu and Yáñez-Mó 2014). CD9 was detected by P2 in 
dorsal forebrain extracts and upregulated by P7 and increased into adulthood 
(Figure 1F). Additionally, CD9 and another EV marker protein, ALIX, were 
detected in primary neonatal SVZ NSC EVs by western blot (Figure 1F and 1G). 
CD9 expression was also confirmed in primary SVZ NSC cultures by 
immunocytochemistry similar to previous reports (Figure 1H and 1I) (Llorens-
Bobadilla et al. 2015). In vivo immunohistochemistry of P0 and P4 brains revealed 
CD9 expression along the ventricular wall in Nestin-positive NSCs beginning at P0 
and increasing by P4 (Figure 1J-1L). Furthermore, CD9 enrichment in the 
neonatal SVZ was consistent with in situ hybridization data collected by the Allen 
Brain Institute (Figure 1M)(Henry and Hohmann 2012). Taken together, these data 
demonstrate that SVZ NSCs release EVs in vitro. 
SVZ NSCs Release CD9 In Vivo 
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To study EV release in vivo, Neuro2a (N2A) cells were first transfected with 
a fluorescent EV marker fusion plasmid, CD9-GFP, and tomato (fluorescent 
protein) (Figure S2A). CD9-GFP was detected in the cytoplasm of N2A cells and 
exosome fractions from sucrose gradients along with ALIX, CD63 and a His-tag 
present within CD9-GFP (Figure S1B). 47% (n = 9, 46.59 ± 4.943) of CD9-GFP-
positive particles were found outside of transfected cells (Figure S2B), consistent 
with the hypothesis that CD9 is released from cells. Exosomes isolated from 
transfected N2A cell conditioned media were incubated with naïve N2A cells. CD9-
GFP could be detected surrounding by not within N2A nuclei suggesting 
cytoplasmic uptake (Figure S2C). To confirm uptake, CD9-GFP-positive 
exosomes were incubated with N2A cells transfected with Tomato fluorescent 
protein. Indeed CD9-GFP could be detected in Tomato-positive cells (Figure 
S2D). Live imaging of N2A cultures transfected with CD9-GFP and Tomato 
fluorescent protein demonstrated considerable movement of intracellular CD9-
GFP (Figure S2E). Finally, release of CD9-GFP was confirmed by live imaging 
(Figure S2F). 
 To study SVZ NSC EVs in vivo, CD9-GFP and Tomato fluorescent protein 
encoding plasmids were electroporated into the SVZ of P0 mice (Figure 2A). 
Tomato fluorescent protein could be detected throughout the soma of 
electroporated cells, whereas CD9-GFP expression was more localized to the 
apical and basal processes of SVZ NSCs (Figures 2B – 2I). CD9-GFP-positive 
cells were more readily found along the ventro-lateral ventricular wall (Figure 2B 
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– 2D). CD9-GFP was expressed in cells with an SVZ NSC morphology, namely an 
apical process that projects to the lateral ventricle and a basal process which 
projected onto a nearby blood vessel (Figure 2E – 2H). Cells with an NSC 
morphology stained positive for Nestin (Figure 2L and 2M), and for glial fibrillary 
acid protein (GFAP) by P7 (Figure 2J and 2K). Additionally, CD9-GFP could be 
detected outside of electroporated cells.  
 At 48 hr post electroporation, we could detect approximately 52 Tomato-
positive cells (Figure 2P). From P2-P7, the number of tomato-positive cells 
decreased by 80% and remained unchanged at P21-P28. This is not surprising 
given that SVZ NSCs generate transit-amplifying cells that produce neuroblasts 
which migrate along the rostral migratory stream to the olfactory bulb. Therefore, 
fluorescence from NSCs expressing plasmid DNA is diluted overtime. NSCs were 
co-electroporated with Tomato and either of two CD9-GFP plasmids containing 
cytomegalovirus (CMV) or CAG promoters. Under the CMV protomer, CD9-GFP 
expression was limited to 7.52% of Tomato-positive cells, whereas CAG-CD9-GFP 
labeled 24% of Tomato-positive cells in the SVZ. Given that CAG-CD9-GFP was 
generated by cloning CD9-GFP into the Tomato plasmid, it is not surprising that 
CAG-CD9-GFP and Tomato co-expression was more abundant. Thus CAG-CD9-
GFP was used for quantification. The percentage of cells co-expressing Tomato 
and CAG-CD9-GFP was compared to the total number of Tomato-positive cells 
decreased from 24% to 7.32% at P7 (Figure 2Q). For every electroporated cell 48 
hr post-electroporation, at least one extracellular particle could be detected (54.77 
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CD9-GFP particles/image) (Figure 2R). The number of CD9-GFP particles found 
outside of co-electroporated cells decreased to 18.20 particles 7 days post-
electroporation and remained similar (19.06) in P21-P28 mice (Figure 2R). Taken 
together, these results illustrate that SVZ NSCs release CD9-GFP, which is soon 
after cleared from the extracellular space.  
SVZ NSCs Selectively Target Microglia 
The reduction of extracellular CD9-GFP  pointed towards a model in which 
NSCs EVs were targeted for removal. Whether or not this process was passive 
(i.e. CSF waste removal) or active was unclear. During early perinatal SVZ 
neurogenesis, there is an influx of microglia. This increase of microglia correlated 
with the observed loss of extracellular CD9-GFP. Therefore, it is likely that 
microglia are responsible for the loss of extracellular CD9-GFP-positive particles. 
To test this hypothesis, immunohistochemistry was used to stain brain sections 
electroporated with CD9-GFP and Tomato with the microglia marker ionized 
calcium-binding adaptor molecule 1 (Iba1). CD9-GFP-positive particles were found 
in proximity of or colocalized with Iba1-positive microglia (Figures 3A and 3B). 
Although in vivo labeling of EVs provided an initial insight into possible targets of 
NSC EVs, the lack of abundance of EVs forced us to investigate other methods to 
study EVs in vivo. As an initial experiment, exosomes from N2A cells transfected 
with CD9-GFP were isolated and labeled with a fluorescent lipophilic dye, DiI (1,1’-
Dioctadecyl-3,3,3’,3’-Tetramethylindocarbocyanine Perchlorate) and transplanted 
into the lateral ventricles of P0 mice (Figure 3C). One to seven days post-
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transplantation, brains were isolated, sectioned, and imaged. A population of cells 
near the lateral ventricles were labeled with DiI and GFP (Figures 3D and 3E). 
Some cells labeled with DiI had a stellate morphology and stained positive for the 
microglia marker Iba1 (Figure 3F).  ~93% (92.84 ± 32.44, n = 8) of DiI exosomes 
co-localized with microglia at P2 and 80% at P7 (79.77 ± 5.448, n = 14) (Figure 
3G). Because of their cancerous origin, N2A cells likely do not mimic NSC-derived 
EVs. Therefore, SVZ NSCs were isolated from P0 mice and placed in culture. P100 
fractions were collected from the SVZ NSC conditioned media and labeled with DiI 
and transplanted into the lateral ventricles of P0 mice. DiI labeled NSC EVs 
predominately targets Iba1-positive microglia (Figure 3H). Labeled microglia were 
often contiguous with the lateral ventricles and found within the SVZ. DiI labeled 
cells also stained positive for two other microglia markers, CD68 and Cd11B, in 
addition to Iba1 (Figures 3I – 3K). Quantification revealed that a majority of NSC 
P100 EV-labeled cells were Iba1 positive (Figure 3L). EVs carry nucleic acids, 
such as mRNA and miRNA. We hypothesized that miRNAs were partially 
responsible for selective targeting to microglia. Therefore, prior to treatment, NSC 
P100 EVs were subjected to UV-treatment, but no significant change in Iba1 co-
localization was detected (control 24 hr = 76.52 ± 4.608, UV-treated 24 hr = 69.64 
± 9.661, control 48 hr = 77.57 ± 6.263. UV-treated 48 hr = 61 ± 8.860) (Figure 3L). 
Exosomes were purified from SVZ NSC EVs, labeled with DiI, and transplanted 
into P0 mice. More than half of all DiI labeled cells were Iba1-positive microglia (P1 
– 57.07 ± 8.134, P2 = 51.46 ± 7.996, P7 = 51.28 ± 12.13) (Figure 3M). Although 
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highly abundant in the developing SVZ, microglia account for less than 10% of total 
cells in the SVZ (Shigemoto-Mogami et al. 2014).  Thus, NSC exosome uptake is 
not random, but is selectively targeted to microglia.  
SVZ NSC EVs Act as a Microglia Morphogen 
 NSC EVs selectively target microglia, but to what effect this has on microglia 
is unclear. To understand the functions of NSC EVs, small RNA sequencing was 
performed. RNA sequencing identified numerous miRNA in NSC P100 EVs, with 
the most abundant miRNAs having reads 10-fold greater than the average miRNA 
(Figure 4A). Specifically, miR-9, Let-7, miR-26, and miR-181 families were highly 
enriched in NSC EVs. Interestingly, members of these miRNA families regulate 
microglia physiology and morphology(Kumar et al. 2015; Lehmann et al. 2012; Yao 
et al. 2014; L. Zhang et al. 2015). Based on previous reports, we hypothesized that 
NSC EVs induce a change in CD11b/Iba1-positive microglia morphology from a 
stellate to a rounded non-stellate phenotype (Figure 4B). NSC P100 EVs 
increased CD11b expression when compared with the contralateral hemisphere of 
transplanted brains (Figure 4E). 24 hr post-transplantation, Iba1/CD11b-positive 
microglia were found contiguous with and on the apical side of the lateral ventricle, 
and in addition, in clusters within the choroid plexus. DiI/CD11b- positive microglia 
found within the ventricle and in the choroid plexus were rounded, having an 
average ellipticity of 0.64, whereas unlabeled CD11b-positive microglia were more 
stellate with a lower ellipticity of 0.36 (Figure 4F). Due to this observation, 
microglia morphology was assessed following NSC P100 EV treatment. Microglia 
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are complex cells that project processes out into the extracellular environment in 
order to sense and survey their surroundings (Nimmerjahn, Kirchhoff, and 
Helmchen 2005). Therefore, we assessed the number of processes in Iba1-
positive microglia both with and without DiI labeling. NSC EV-labeled microglia 
were less complex than non-labeled cells within the same SVZ. This phenotype 
persisted up to seven days (Figure 4G). UV pretreatment of SVZ NSC exosomes 
reversed the reduced complexity phenotype (Figure 4H). Because UV treatment 
was able to partially rescue the non-stellate morphology of microglia, we concluded 
that the content of NSC exosomes, and likely EVs, is important for the 
morphological changes of microglia. The Let-7 family was the most abundant 
miRNA found in NSC EVs, therefore we hypothesized that Let-7 might regulate 
microglia morphology. Exosomes isolated from N2A cells transfected with a Let-7 
sponge were collected. Exosomes were then transfected with either a mock or 
synthetic Let-7 and subsequently transplanted into P0 lateral ventricles. 
Interestingly, synthetic Let-7 miRNA transfected exosomes, but not the mock, 
induced a morphological shift in microglia, similar to the shift caused by NSC EVs 
(Figures 4I-4L). Taken together, these results confirm that SVZ NSCs release EVs 
that are targeted to, taken up by, and modify microglia.  
NSC EVs Activate a Microglia Transcriptional Network, Resulting in an NSC 
Feedback Loop 
Primary cultures of microglia were subjected to next-generation RNA sequencing 
following NSC EV treatment. In cultures treated with NSC EVs, 1,713 transcripts 
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were upregulated by greater than 2-fold, and 1,175 were significantly 
downregulated by greater than 2-fold (Figure 5A). Gene ontology analysis 
revealed that immune system processes and inflammatory responses were the 
most highly enriched and significantly represented terms (Figure 5B). A heat map 
of altered transcripts revealed that the most highly upregulated transcripts included 
cytokines such as interleukin-1α (IL-1α), IL-1β, and IL-6 (Figure 5C). This 
observation was consistent with network analysis which included a cytokine node 
at the core of this network (Figure 5D). Luminex assay was performed on microglia 
conditioned media either treated or untreated with NSC EVs. The cytokine profile 
from treated vs. untreated microglia was consistent with the transcriptional data in 
that upregulated transcripts, such as IL-1α, IL-1β, and IL-6, were also increased in 
the cytokine profile of treated microglia (Figure 5E). Regulation of cytokines is 
likely dependent on NSC exosome content. Since Let-7 was the most abundant 
miRNA transcript detected and since Let-7 activates the endosomal TLR-7 
receptor(Lehmann et al. 2012), we investigated whether Let-7 family members 
could modulate transcriptional changes that induce cytokine responses in 
microglia. Plasmids expressing Let-7 sponges were transfected into N2A cells. 
N2A media was collect and EVs were isolated using an ultracentrifugation protocol 
(P100 EVs). Synthetic Let-7 miRNAs were transfected into isolated P100 EVs and 
transfected EVs were used to treat cultures of microglia. Measured cytokine 
responses revealed that synthetic Let-7-containing P100 EVs stimulated robust 
release of cytokines from microglia that mimicked the effect of NSC EVs (Figure 
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5F). Interestingly, when NSC EVs were used to treat RAW 264.7 macrophages, 
the cytokine response differed from microglia (Figure S3). For example, 
macrophages released IL-1α, IL-6, and granulocyte-colony stimulating factor (G-
CSF), whereas G-CSF was not increased for treated microglia, and IL-1β was 
unchanged in macrophages after NSC EV treatment. Suggesting that depending 
on the source of EVs, varied responses in target cells are observed. We 
hypothesized that the release of factors from microglia following exosomes uptake 
may exert a feedback response to SVZ NSCs. To test this, microglia conditioned 
media from NSC EV treated and untreated microglia was depleted of EVs and 
injected into the lateral ventricles of P0 mice. EdU (5-ethynyl-2’-deoxyuridine) 
labeling was performed 2 hr prior to tissue harvesting (Figure 5G). Conditioned 
media from treated microglia with NSC EVs, but not untreated microglia, caused a 
reduction in the number of dividing NSCs in the SVZ (Figure 5H). Taken together, 
these results demonstrated a robust and significant effect of SVZ NSC EVs on 
microglia signaling that results in a negative feedback loop to NSCs during early 
postnatal development.  
Discussion: 
 In this study, we provide evidence of EV release from SVZ NSCs that are 
selectively targeted to microglia. NTA, western blotting and EM were used to 
confirm the release of EVs from primary SVZ NSCs. Fluorescent staining in vivo 
and in vitro confirmed the presence of EV marker protein CD9 in Nestin-positive 
NSCs. CD9 was found to be highly enriched in EV fractions, including EVs isolated 
90 
 
from N2A cells. These findings support other reports of CD9 in stem and stem-like 
cells, including adult SVZ NSCs (Bolukbasi et al. 2012; Karlsson et al. 2013; Kolle 
et al. 2009; Leung et al. 2011; Llorens-Bobadilla et al. 2015; Terada et al. 2002).   
 The CSF of embryonic and postnatal brains contain an abundance of EVs, 
but the sources, targets. and function are mostly undiscovered (Feliciano et al. 
2014; Tietje et al. 2014). One study reported that CSF EVs isolated from rat 
embryonic CSF had a proliferative effect on mixed NSC cultures (Feliciano et al. 
2014). Due to their location at the latero-ventricular interface, we investigated 
whether SVZ NSCs were a possible source of CSF EVs. Neonatal electroporations 
were preformed using CD9 fused to a green fluorescent tag (CD9-GFP). 
Extracellular CD9-GFP could be detected 48 hrs post-electroporation near Nestin-
positive cells in the SVZ.  Previous studies have identified the release of particles 
during neurogenesis whose targets and functions are not well understood (Das 
and Storey 2014; Dubreuil et al. 2007). For instance, neuroepithelial stem cells 
(NESCs) release a particle from the midbody during NESC progenitor pool 
expansion (Dubreuil et al. 2007). Thus, SVZ NSC EVs simply add to a growing list 
of the ever-increasing developmental EVs. 
 The number of extracellular CD9-GFP particles decreased over time. This 
reduction correlated with the influx of microglia into the SVZ of the neonatal brain. 
To unbiasedly identify the targets of SVZ NSC EVs, EVs were labeled with the 
lipophilic dye DiI, and transplanted into the lateral ventricles of P0 mice. We 
discovered that a majority of DiI labeled SVZ NSC EVs target Iba1/CD11b/CD68-
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positive microglia. However, how EVs are targeted to microglia remains unclear. 
Other studies have also documented the uptake of oligodendrocyte and glioma 
exosomes by microglia (Fitzner et al. 2011; van der Vos et al. 2016). Since EVs 
carry various RNA species, including miRNA, and that other studies have identified 
the regulatory role of miRNA on microglia morphology and physiology, next-
generation small RNA sequencing was used to identify miRNA content within SVZ 
NSC EVs. Several miRNA families were enriched in SVZ NSC EVs including miR-
9, lethal-7 (let-7), and miR-181. Due to previous findings of miRNA regulation of 
microglia, we hypothesized that NSC EVs may function as a non-canonical 
microglia morphogen. Indeed, NSC EV uptake in microglia resulted in a 
morphological shift from a stellate to a rounded morphology, in agreement with 
previous reports (Kumar et al. 2015; Lehmann et al. 2012; Yao et al. 2014; L. 
Zhang et al. 2015). Since EVs also carry non-nucleic acids components, we cannot 
rule out the possibility of other NSC EV cargo contributing to the observed effects 
on microglia. 
 RNA sequencing of NSC EV treated microglia revealed a significant change 
in transcriptional networks. Of the transcripts, a notable change was associated 
with the immune system gene ontology terms, including immune system process, 
inflammatory response, defense response to viruses, neutrophil chemotaxis, 
positive regulation of cytokine secretion, and I-kappa B kinase/nuclear factor κB 
(NF-κB) signaling. In agreement with transcriptional changes, Luminex analysis of 
cytokine profiles showed an increased secretion of IL-6, IL-1α, and IL-1β from 
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treated microglia. Let-7 transfected EVs were sufficient to alter treated microglia 
cytokine profiles, although how this occurs is unclear. To understand the 
consequences of the altered cytokine profiles of treated microglia, microglia 
conditioned media was depleted of EVs and injected into the lateral ventricles of 
P0 mice. Transplantation of conditioned media from treated microglia resulted in a 
reduction of the number of proliferating SVZ NSCs, as determined by EdU labeling. 
Other studies have also reported the regulatory effect of microglia on dentate gyrus 
and embryonic ventricular zone NSCs (Cunningham, Martínez-Cerdeño, and 
Noctor 2013; Gebara et al. 2013). 
 The results of this study are two-fold: 1) EVs act as a method of intercellular 
communication and 2) SVZ NSC EVs are targeted to and alter microglia physiology 
and morphology. We propose that during neonatal SVZ neurogenesis, SVZ NSCs 
release EVs that act as a non-canonical microglia morphogen which affect the 
phenotype, location, and function of microglia in the developing brain. Many 
studies have reported the presence of EVs in normal and pathophysiological states 
during development and disease. While NSC EVs are just one population of EVs 
that likely contribute to normal brain development, future studies will be required 
to understand the far-reaching implications of SVZ NSC EVs in development and 
disease.  
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Experimental Procedures 
Animals 
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Experiments were performed according to guidelines set forth by the Clemson 
University Institutional Animal Care and Use Committee and NIH Guide for the 
Care and Use of Laboratory Animals. Pregnant CD-1 mice obtained from Charles 
River Laboratories were housed under pathogen-free conditions with a 12-hr 
light/dark cycle. For primary cell culture, EV and exosome preparation, 
and sequencing, pooled samples of both genders were used. 
 
Cell Culture, Transfections, and Immunocytochemistry 
N2a mouse neuroblastoma cells (American Type Culture Collection CCL-131) 
were maintained in tissue culture-treated polystyrene multi-well plates or flasks 
(Falcon; BD Biosciences Discovery Labware) in a 37°C incubator with 5% CO2. 
N2a cells were routinely propagated and DNA transfections were performed with 
PolyJet (SignaGen Laboratories) as previously described (Feliciano et al. 2013b).  
 
For immunocytochemistry experiments, when Neuro-2a cells reached 80-90% 
confluence, they were passaged onto circular coverslips in six-well plates 24 hours 
prior to transfection. Cells were then transfected with PolyJet (SignaGen 
Laboratories) with DNA vectors according to manufacturer’s recommendations. 48 
hours post-transfection, cells were subjected to live imaging (see below) or fixed 
using 4% paraformaldehyde in 1X DMEM by replacing half of the media three 
consecutive times. In short, half of the DMEM media was removed and replaced 
with 4% PFA. This was repeated three times over a course of 10 minutes. 
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Coverslips were then rinsed three times in wash buffer (PBS, 0.1% Tween-20) and 
incubated with 1 nM TO-PRO-3 Iodide (Topro) in DMSO (Life Technologies). 
Coverslips were then washed sequentially in wash buffer and 1X PBS and 
mounted in ProLong Gold antifade reagent (Life Technologies) and imaged at 
described.  
 
Live Imaging 
24-48 hrs after transfection of N2a cells with CD9-GFP and Tomato plasmids, 
coverslips containing cells were placed in a perfusion chamber. Cells were 
continuous perfused using pre-warmed culture media (37°C) through a pump 
(Harvard Apparatus, Catalog # 70- 2027)/vacuum system (Warner Instruments, 
Model # 64-1940 (DMV). Cells were subjected to live imaging in 4 hr intervals. 
Movies were collected, and representative snapshots were chosen for further 
analysis. 
Electroporation 
Electroporations were performed as described previously (Feliciano et al., 2013). 
Briefly, DNA combined with fast green was injected into the lateral ventricle. Pups 
were electroporated with a BTX ECM 830 Square Wave Pulse generator and 
Tweezertrodes (Harvard Apparatus). 
Slice Preparation and Immunohistochemistry 
Slices were prepared as described previously (Feliciano et al., 
2011). Antibodies used included Nestin (Novus Biologicals, NB100-
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1604), CD9 (eBioscience, 14-0091-81), Iba1 (Novus, NB100-2833), CD68 (Bio-
Rad, MCA1957), CD11b (Bio-Rad, MCA711G), or GFAP (Cell Signaling 
Technology, 12389S). Secondary antibodies conjugated to Alexa Fluor 488 or 
Alexa Fluor 633 (Life Technologies) were incubated overnight at 4°C. 
Imaging 
Images were taken on a Leica TCS SPE spectral confocal microscope using 20×, 
40×, or 63× oil immersion lenses. Images were processed using Leica Application 
Suite X software (Leica Microsystems). 
Exosome Isolation 
Supernatant was collected and centrifuged at 300 × g for 10 min and 2,000 × g for 
10 min, followed by 100,000 × g centrifugation in a Beckman Coulter Optima MAX-
XP with a TLA 100.3 rotor for 90 min (P100 fraction). EVs were then subjected to 
further purification via sucrose density gradients consisting of 8%, 30%, 45%, and 
60% layers in PBS and centrifuged at 232,000 × g for 30 min to 18 hr at 4°C. 10 
fractions were collected, diluted 1:10 in PBS, and centrifuged for 1 hr at 
100,000 × g. Each fraction was re-suspended in 4× Laemmli buffer and subjected 
to western blotting or PBS for further analysis. For 
exosome transfection experiments, P100 fractions were resuspended in 2.5 M 
sucrose, and density gradients were constructed from 2.5 M to 0.25 M (2.5 M, 2 
M, 1.5 M, 1 M, 0.5 M, and 0.25 M). Gradients were centrifuged at 100,000 × g for 
18 hr at 4°C. 10 Fractions were collected and diluted 1:10 in PBS and centrifuged 
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for 1 hr at 100,000 × g at 4°C. Fractions were resuspended in Dulbecco’s PBS and 
stored at –20°C. 
Electron Microscopy 
Preformed at Department of Cellular and Molecular Physiology, Yale University 
School of Medicine. 
 EVs suspended in 4% paraformaldehyde were embedded in a formvar carbon-
coated grid, washed in PBS, fixed in 1% glutaraldehyde, and stained with saturated 
aqueous uranyl oxalate. EVs were embedded in 0.4% w/v uranyl acetate and 
1.8% w/v methylcellulose. Samples were imaged with a Carl Zeiss 910 electron 
microscope (Carl Zeiss Microscopy, Thornwood, NY). 
Neonatal Transplantation and Click-iT EdU Labeling 
DiI-labeled P100 fractions were preloaded into capillary tubes and loaded with 
2 μL of EV/DiI/PBS mixture, and EVs were injected into the lateral ventricle. Pups 
were placed onto a heating pad for 5 min until recovered and placed back into 
cages. Medium collected from cultured microglia was loaded into capillary tubes, 
and approximately 2 μL of medium was transplanted into the lateral ventricles of 
P0 pups. The Click-iT EdU imaging kit (Invitrogen, C10338) was used according 
to the manufacturer’s protocol to assess proliferation. 
DiI Labeling of P100 Fractions 
P100 fractions were isolated as described above. P100 fractions were centrifuged 
at 14,000 × g for 30 min. Pellets were re-suspended in PBS and subjected 
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to DiI labeling (1:1,000 at room temperature [RT], Life Technologies, V22889) for 
10 min while vortexing periodically during incubation. DiI-labeled P100 fractions 
were centrifuged at 14,000 × g for 30 min and re-suspended in 1× PBS. 
Centrifugation was repeated a total of three times. The final pellet was re-
suspended in 50 μL 1× PBS and stored at –20°C. 
Western Blot 
Samples were lysed in radioimmunoprecipitation assay (RIPA) buffer, 2% SDS, 
and Halt protease and phosphatase inhibitor cocktail (Thermo Fisher Scientific). 
Samples were placed on ice, sonicated with a Q55 sonicator (Qsonica), and 
centrifuged, and the supernatant was placed into fresh tubes. The following 
antibodies were used: CD63 (1:1,000, System Biosciences), CD9 (1:1,000, 
System Biosciences), ALIX (3A9, 1:1,000, Cell Signaling Technology, 21711), β-
tubulin III (Aves Labs, TUJ), or His tag (D3I1O, 1:1,000, Cell Signaling Technology, 
12698). Horseradish peroxidase (HRP)-conjugated antibodies from Life 
Technologies were used as a secondary antibody (1:3,333–1:5,000). 
Polyvinylidene fluoride (PVDF) membranes were incubated with ECL substrate 
(Pierce) and exposed to Amersham Hyperfilm ECL (GE Healthcare). 
Primary Neural Stem Cell Culture and Immunocytochemistry 
The protocol was derived from Walker and Kempermann (2014). Cells 
were cultured in 500 μL Neurobasal A complete medium (1X Glutamax, 
50 units/mL penicillin/streptomycin, 20 ng/mL epidermal growth factor (EGF), 
20 ng/mL fibroblast growth factor 2 (FGF-2), and 2% B27 Supplement). Cells were 
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placed on laminin-coated plates or coverslips in 24-well plates in Neurobasal A 
complete medium. The following day, complete media was refreshed, and the 
supernatant was stored at –20°C. 
24 hr later, culture medium was collected and used for exosome and P100 
isolation. Cells were lysed with 1X RIPA, 2% SDS, and PBS and used for western 
blotting or fixed by adding equal volumes of 37°C fixative solution (4% 
paraformaldehyde in 300 mM sucrose and Neurobasal A) directly to the wells and 
incubated at 37°C for 10 min. Coverslips were then washed three times, blocked 
in antibody buffer (PBS, 2% BSA, and 0.1% Tween 20) with 0.1% Triton X-100 and 
then washed again three times. Coverslips were incubated with antibodies against 
anti-CD9 mouse (eBioscience, 1:1,000), Nestin (Novus, 1:1,000), Iba1 (Vector 
Laboratories, VP-RM04, 1:500), and DCX (Santa Cruz Biotechnology, C-18, 
1:500), washed three times, and then incubated in antibody buffer with the 
appropriate secondary antibodies (1:1,000, Life Technologies). Following four 15-
min washes, coverslips were mounted in ProLong Gold Antifade with DAPI (Life 
Technologies) on Superfrost microscope slides (Thermo Scientific). 
Analysis: Distribution 
Co-localization and distribution of CD9-GFP in electroporated postnatal neural 
stem cells were analyzed using Fiji. Z stack images were loaded into Fiji software, 
Z-projected (Max Intensity), and separated from stacks to images based on 
fluorescent channels (i.e., green, red, or blue). Brightness/contrast was adjusted 
for each Z-projected image to reduce background noise. Using the Co-localization 
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plugin in Fiji, Z-projected images were assessed for co-localization of CD9-GFP 
and Tomato. The co-localization threshold of each image was set between 85–130 
using 5-point increments when adjusting. Images were subjected to particle 
analysis through the Analyze Particle plugin. Green particle size was set from 1 
micron to infinity to detect small CD9-GFP particles, and Tomato particle size was 
set from 10 microns to infinity to only count the number of cells and not cell debris. 
The percentage of CD9-GFP and Tomato co-localization was recorded. 
DiI and Cell Type Co-localization (Iba1, CD11b, and CD68) 
Images were loaded into Fiji (ImageJ) and converted into composite images. 
Z sections were selected based on DiI and Iba1/CD11b/CD68 co-localization 
within the selected Z section. Selected sections were Z-projected using max 
project and separated into individual color channels. Brightness and contrast were 
adjusted to correct for background noise within each image. Co-localization 
analysis was performed on Z-projected DiI and Iba1/CD11b/CD68 images. Co-
localized images were converted to 8 bits, inverted, and thresholded to 0 and 255 
(only co-localized particles were visible). Thresholds of Z-projected DiI and 
Iba1/CD11b/CD68 images were set to 10/255 and 85–100/255, respectively. All 
images were then subjected to particle analysis. The percentage of co-localized 
DiI particles was in relation to the total number of DiI particles. 
Morphological Analysis: Ellipticity and Process Number 
Cellular ellipticity was measured using Shape Description in Particle Analysis in 
ImageJ. Images were loaded into ImageJ, Z-projected, and separated into 
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individual channels (green, red, and blue). Thresholds were set at 100–120 and 
255. Cells either in the SVZ or in the ventricular wall were outlined using the 
freehand tool and assessed through particle analysis. Circularity was reported as 
a value between 0 and 1, with 1 describing a perfect circle. Microglia complexity 
analysis was conducted using Leica Application Suite X (LASx) 1.1.0.12420 3D 
module software. Processes of Iba1+ cells were quantified manually in the 3D 
module. The average number of processes in DiI+/Iba1+ cells was compared with 
DiI-/Iba1+ cells. 
Nanosight Particle Tracking Analysis 
Samples were shipped on wet ice to the Nanomedicine Characterization Core 
facility in the Center for Nanotechnology in Drug Delivery at the University of North 
Carolina (UNC) at Chapel Hill. Samples were prepared in a laminar flow hood and 
thawed at RT. Sample dilutions were based on an initial run with PBS, 10 mM salt. 
Samples were loaded onto a pre-cleaned and pre-warmed Nanosight NS 500 
nanoparticle characterization system (NanoSight, UK) equipped with a 532-nm 
laser and a 565-nm long pass filter. Mean size and particle concentration values 
were calculated by the nanoparticle tracking software. The Nanosight NS 500 was 
calibrated with 100 nm polystyrene latex microsphere standards (Nanosight, UK), 
and readings were acquired at 23.3°C. 
RNA Sequencing 
Small RNA sequencing was performed by System’s Biosciences (SBI). RNA 
Sequencing of microglia was performed by GeneWiz. 
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For EV small RNA sequencing, RNA was isolated by Trizol extraction from EVs 
from P100 fractions of primary SVZ NSCs. Samples were quantified using the 
Agilent Bioanalyzer small RNA assay. Libraries were prepared according to 
manufacturer’s protocol (Illumina small RNA preparation kit). Samples were 
subjected to 1 × 75 bp single-end reads at an approximate depth of 10–15 million 
reads per sample on an Illumina Hi-Seq. 
RNA was isolated from microglia cell cultures using Trizol in accordance with the 
manufacturer’s protocol. Three samples from 1–2 RNA isolations for each 
condition were used to generate libraries. RNA concentrations and purity were 
assessed by Nanodrop, Qubit assay, and Agilent Tapestation. RNA library 
preparation with poly(A) selection was performed using the NEBNext Ultra RNA 
Library Preparation Kit according to the manufacturer’s protocol (New England 
Biolabs). 2 × 150 bp reads were generated at a depth of 56–84 million reads per 
sample on an Illumina HiSeq. Samples had a mean quality score of 38.52, with 
92.76% of bases having a ≥ Q30 score. Sequence reads were trimmed to remove 
possible adaptor sequences and nucleotides with poor quality using Trimmomatic 
v0.36. The reads were then mapped to the Mus musculus GRCm38 reference 
genome available on ENSEMBL using the STAR aligner. The RNA sequencing 
(RNA-seq) aligner is executed using a splice aligner that detects splice junctions 
and incorporating them to help align the entire read sequences. Unique exon hit 
counts were calculated using feature counts from the Subread package. After 
mapping and unique exon hit count calculations, downstream 
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differential expression analysis was performed using DESeq2. Gene ontology 
(GO) analysis was performed on the statistically significant set of genes by 
implementing the software GeneSCF. The Mouse Genome Informatics GO list was 
used to cluster the set of genes based on their biological process and determine 
their statistical significance. Gene interaction networks were determined by 
Cytoscape 3.60 using Genemania. 
Luminex 
Cytokine concentrations were quantified with the cytokine multiplex assay from 
Bio-Rad as described previously (Racicot et al., 2017). Wells of a 96-well filter 
plate were loaded with 50 μL of prepared standard solution or 50 μL of cell-free 
supernatant and incubated with the Bio-Plex Pro mouse 23-plex assay from Bio-
Rad at ± 800 rpm for 30 min in the dark at RT. Wells were vacuum-washed three 
times with 100 μL wash buffer. Samples were then incubated with 25 μL of 
biotinylated detection antibody at ± 800 rpm for 30 min at RT in the dark. After 
three washes, 50 μL of streptavidin-phycoerythrin was added to each well and 
incubated for 10 min at ± 800 rpm at RT in the dark. After a final wash, the beads 
were resuspended in 125 μL of sheath buffer for measurement with the Luminex 
200 (Luminex, Austin, TX) 
Microglia Culture 
24 hr prior to plating microglia, 6 well plates were coated with 10 μg/mL poly-L-
lysineaccording to the supplier’s instructions. The protocol was derived 
from Bohlen et al. (2017). Primary microglia cells isolated from CD1 mice were 
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reconstituted in a 37°C water bath immediately prior to plating. 
For immunohistochemistry following exosome treatment experiments, 3,500 cells 
were plated in 500 μL microglia complete medium (2 ng/mL TGF-β2, 
100 ng/mL IL-34, 1.5 mg/mL cholesterol, 100 units/mL penicillin-streptomycin 
[pen-strep], 1× Glutamax, and microglia medium [Sciencell, 1901]) and allowed to 
adhere for 10 min at RT in 24-well plates. 
Exo-fection 
After sucrose density gradient isolation of Neuro-2a exosomes or 
extracellular vesicles, the respective vesicles were transfected (System 
Biosciences, EXFT10A-1). In brief, isolated vesicles were mixed with 10 μL Exo-
Fect solution, synthetic Let-7 miRNAs (Sigma; HMI0007, HMI0009, and HMI0017, 
which also correspond to mouse Let-7), and Dulbecco’s phosphate-buffered 
saline (dPBS). Tubes were incubated at 37°C for 10 min then immediately placed 
on ice. Samples were centrifuged at 14,000 x g for 15 min at 4°C. Samples were 
either used to treated cultured primary microglia or labeled with DiI and injected 
into the lateral ventricles of P0 pups as described previously. 
Statistics 
Statistics were performed with Prism software (version 6; GraphPad). Significance 
was calculated using unpaired t tests and one-way ANOVA with Tukey’s multiple 
comparisons test. Statistical significance was defined as p < 0.05. All data are 
presented as mean ± SEM. The Wald test, p values, and absolute Log2Fold 
changes were generated for gene expression analysis. Genes with adjusted p < 
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0.05 and absolute Log2Fold change > 2 were called as differentially expressed 
genes for each comparison. 
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Figure 1. Neonatal SVZ NSCs Release EVs 
(A) Immunocytochemistry for Nestin (green) and TO-PRO-3 (blue) in primary 
cultures of P0 SVZ NSCs 48 hrs after culture initiation. Scale bar, 25 μm.(B) 
Nanosight particle profile of EVs derived from the P100 fraction of SVZ NSCs. 
(C) Electron micrograph of an NSC-derived exosome. Scale bar, 100 nm. 
(D) Western blot of CD63 in NSC lysate or NSC EV P100 fractions. (E) Western 
blot of CD9 and β3-tubulin from dorsal forebrain extracts. (F) Western blot for 
ALIX in SVZ NSC EV P100 fractions as in (D). (G) Western blot for CD9 from 
NSC EV P100 fractions as in (D). (H and I) Immunohistochemistry of Nestin 
(green), TO-PRO-3 (blue), CD9 (red) (H), and CD9 (I) in P0 SVZ NSC cultures. 
Scale bars, 12.5 μm. (J) Nestin (green) and CD9 (red) expression within the 
SVZ at P0. Scale bar, 5 μm. (K and L) Nestin (green), CD9 (red), and TO-PRO-
3 (blue) within the SVZ at P4. Scale bars, 25 μm. (M) In situ hybridization of 
CD9 in a P14 sagittal brain section from the Allen Brain Institute Developing 
Mouse Brain Atlas. Image credit: Allen Institute. 
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Figure 2. SVZ NSCs Release CD9 In Vivo 
(A) Schematic diagram of a coronal section, indicating the direction of electrodes 
used for neonatal electroporation; black rectangles indicate the corresponding 
regions imaged. Image credit: Allen Institute. (B) 5x image of the SVZ of a P2 
mouse following P0 electroporation with Tomato (red) and CD9-GFP (green). 
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Scale bar, 100 μm. (C) 20x image of the dorsolateral SVZ from (B). Scale bar, 
50 μm. (D) 20x image of the ventro-lateral SVZ from (B). Scale bar, 50 μm. (E–H) 
63x images of SVZ NSCs electroporated with Tomato (red) and CD9-GFP (green) 
demonstrating differences in CD9-GFP localization in apical and basal processes 
(E) and soma(F). Note the distribution of Tomato and CD9-GFP (G, merge) and 
CD9-GFP alone (H). Scale bars, 50 μm. (I) CD9-GFP distribution in relation to the 
Tomato-positive SVZ NSC soma located at the ventricle. Arrows point to CD9-GFP 
in the basal fiber, and arrowheads point to apical fibers with CD9-GFP present. 
Scale bar, 50 μm. (J) SVZ from a Tomato-electroporated (red) and CD9-GFP-
electroporated (green) mouse stained for GFAP (blue). Scale bar, 25 μm. (K) 
Individual Z section from (J). Scale bar, 25 μm. (L) 20x image of a CD9-GFP-
electroporated (green) and Tomato-electroporated (red) brain stained 
for Nestin (white). Scale bar, 25 μm. (M) Individual Z section from (L). Scale bar, 
25 μm. (N) 63x zoom-2 image within the SVZ of Tomato-electroporated (red) and 
CD9-GFP-electroporated (green) mice showing extracellular CD9-GFP-positive 
particles. Scale bar, 5 μm. (O) A tracing of an individual slice showing a Tomato-
positive cell body (red) and CD9-GFP (green). (P) Quantification of the number of 
Tomato-positive SVZ cells from P2–P28. (Q) Quantification of CD9-GFP and 
Tomato-positive cells in the SVZ from P2–P28. (R) Quantification of the number of 
extracellular CD9-GFP-positive particles in the SVZ from P2–P28. See 
also Figure S1. Data are represented as mean ± SEM. ∗∗p < 0.01, ∗∗∗p < 
0.001, ∗∗∗∗p < 0.0001. 
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Figure 3. NSC EVs Selectively Target Microglia 
(A) 20x image showing Iba1-positive microglia (blue) in proximity to Tomato-
electroporated (red) cells and CD9-GFP-positive particles (green). Scale bar, 
50 μm. (B) 20x image of (A). (C) Schematic of EV transplantations. (D and 
E) DiI (D) and CD9-GFP (E, green) fluorescence within the SVZ of P7 brains 
following CD9-GFP N2A EV transplantation. Scale bar, 50 μm. (F) Brain 
transplanted with DiI-labeled EVs (red) and stained for the microglia 
marker Iba1(white). Scale bar, 50 μm. (G) Quantification of co-localization of Iba1 
and DiI following N2A transplantations and analysis at P2 and P7. (H) 20x image 
of a lateral SVZ following primary NSC DiI-labeled EV (red) transplantation stained 
for Iba1 (green). Scale bar, 50 μm. (I) 20x image of a dorso-lateral SVZ following 
primary NSC DiI-labeled EV (red) transplantation stained for CD68 (green). Scale 
bar, 50 μm. (J and K) 20× (J) and 63x (K) image of SVZ following primary NSC DiI-
labeled EV (red) transplantation stained for CD11b (green) and Iba1 (white). Scale 
bars, 25 μm. (L) Quantification of Iba1 co-localized EVs without (green) or with 
(red) UV treatment from NSC EV transplantations. (M) Quantification of the 
number of Iba1-positive, DiI-positive cells in the SVZ from P1–P7 from NSC 
exosome transplantations. Data are represented as mean ± SEM. 
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Figure 4. NSC EVs Act as a Microglial Morphogen 
(A) Identity and quantity of NSC EV miRNAs. (B) Schematic of predicted NSC EV 
miRNA functions. (C and D) Image demonstrating CD11b-labeled (green) cells in 
DiI-labeled EV-transplanted (red) ipsilateral (C) or contralateral (D) hemispheres. 
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Scale bar, 25 μm. (E) Quantification of the percentage of CD11b- or CD68-
positive microglia. (F) Measurement of regional microglia ellipticity. (G) Average 
number of cellular processes in Iba1-positive microglia following EV 
transplantation. (H) Quantification of the number of cellular processes in Iba1-
positive microglia labeled by control or UV pre-treated NSC exosomes. (I) 
Quantification of the number of cellular processes following treatment with control 
N2A exosomes or N2A exosomes packaged with synthetic Let-7. (J and K) 
Representative images of control (J) or Let-7 (K) EV transplantations from (I). 
Scale bars, 50 μm. (L) Quantification of microglia ellipticity following control or Let-
7 exosome uptake. Data are represented as mean ± SEM. ∗p < 0.05, ∗∗∗p < 
0.001, ∗∗∗∗p < 0.0001. 
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Figure 5. NSC EVs Activate a Microglia Transcriptional Network, Resulting in 
an NSC Feedback Loop 
(A) Volcano plot of p values and fold changes of microglia mRNAs after NSC EV 
treatment. (B) Gene ontology terms represented by p value and number of genes 
changed in the microglia gene network. (C) Bi-clustering heatmap of the top 30 
significantly altered mRNAs from control or NSC EV-treated microglia. (D) Gene 
network analysis of the top differentially expressed microglia mRNAs 
demonstrates clustering of cytokines and cytokine receptors. (E) Cytokine levels 
in medium from control and NSC EV-treated microglia. (F) Cytokine levels from 
microglia-conditioned medium from N2A control and synthetic Let-
7 transfected exosomes. #, = fluorescence. (G) Representative images of brains 
injected with control or NSC EV microglia-conditioned medium, Edu-labeled 
(green), subjected to immunohistochemistry for Nestin (red), and counterstained 
with TO-PRO-3 (blue). Scale bar, 25 μm. (H) Quantification of the percentage of 
EdU-positive, Nestin-positive neural stem cells. See also Figure S2. Data are 
represented as mean ± SEM. ∗∗p < 0.01. 
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Figure S1: 
 
Figure S1. Western blot of primary SVZ NSC lysates. A) Western blot of primary 
SVZ NSC lysates were probed for the NSC marker Nestin. Nestin = 176 kDa.  
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Figure S2: 
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Figure S2. CD9 is Released with N2A EVs, Related to Figure 2.  
A) Image of N2A cells transfected with CD9-GFP (green) and Tomato (red) and 
DNA counter-stained with TO-PRO-3 (blue). B) N2A EVs were subjected to 
sucrose gradient fractionation and subsequently western blotted for CD9, Alix, 
CD63, and His-tag. P=P100 fraction. C) Quantification of the percentage of 
extracellular CD9-GFP. D) Exosomes from CD9-GFP (green) transfected N2A 
cells were isolated and incubated with naïve N2A cells and counterstained for 
TO-PRO-3 (grey). E) Same experiment as D with the exception that CD9-GFP 
exosomes (green) were added to tomato (red) transfected N2A and imaged. F) 
Live imaging of CD9-GFP (grey) and tomato transfected N2A cells with CD9-
GFP particle trajectories labeled (multi-color). G) Live imaging of tomato (red) 
and CD9-GFP (green) transfected N2A cells. Arrow points to CD9-GFP being 
released. Data are represented as mean ± SEM. 
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Supplemental Figure 3: 
 
Figure S3. Effect of NSC EVs on RAW 264.7 Cytokine Profile, Related to 
Figure 5. A) Quantification of cytokine concentration in RAW 264.7 cell media from 
control (blue) and NSC EVs (red) treatments. Data show mean values (± standard 
error of the mean (SEM), n=6 from 3 independent samples read in duplicate). 
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CHAPTER FOUR 
 
A CRE-Recombinase-Inducible and Fluorescent Extracellular Vesicle Transgenic 
Model System Labels Neural Stem Cells in the Subventricular Zone of Neonatal 
Mice 
 
ABSTRACT 
 Extracellular vesicles (EVs) are primarily membrane-derived vesicles that 
transfer encapsulated RNA and protein from donor to recipient cells. EV content is 
dependent upon its cell of origin and thus each EV generated contains a unique 
molecular signature. Tetraspanin proteins, namely CD9, CD63, and CD81, have 
been used to identify and characterize EVs. EV marker proteins fused to 
fluorescent tags have been utilized to study EVs in vitro and in vivo. Recently, 
transgenic model systems have been generated to better understand EV 
implication in development. Subventricular zone (SVZ) neural stem cells (NSCs) 
reside at the lateral-ventricular interface of neonatal and adult mice. SVZ NSCs 
generate multiple cells types including olfactory bulb neurons and astrocytes. 
Moreover, SVZ NSCs interact with EV containing cerebrospinal fluid (CSF) 
throughout life. In the present study, a CRE-recombinase inducible expression 
plasmid where CD9 was fused to GFP derived from the copepod Pontellina 
plumata (CD9-GFP) was used to identify CD9-GFP-positive EVs in SVZ NSCs. 
Electroporation of CRE-recombinase into CD9-GFP mice resulted in expression of 
CD9-GFP in a subset of cells within the SVZ. Moreover, CD9-GFP expression was 
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detected in Nestin-positive cells in the SVZ. These results demonstrate the utility 
of CD9-GFP mice to study EVs in vivo. Future studies using CD9-GFP mice can 
be accomplished in a cell-type and time specific manner.  
INTRODUCTION 
        Extracellular vesicles (EVs) are nanometer-sized vesicles that carry 
molecular cargo, such as miRNA, mRNA, and protein (Théry et al. 2006; Raposo 
and Stoorvogel 2013; Maas, Breakefield, and Weaver 2017; Morton and Feliciano 
2016). Molecular cargo of EVs is dependent on its cell of origin.  In glioma stem 
cells, exosome-associated miRNA was reflective of the cellular transcriptome (Wei 
et al. 2017).  Furthermore, in a study regarding alcoholic hepatitis, inflammatory 
miRNAs found in exosomes isolated from rodent and human sera were enriched 
in alcohol-treated conditions (Momen-Heravi et al. 2015). Validation of exosome 
miRNA between species and treatment conditions demonstrated the potential use 
of exosomes as a diagnostic biomarker tool. Three types of EVs have been 
described: exomeres, exosomes, and microvesicles ((Théry, Zitvogel, and 
Amigorena 2002; Zhang et al. 2018; Maas, Breakefield, and Weaver 2017). 
Exomeres are comprised of metabolic, translational, and coagulation regulating 
proteins, and unlike other EVs, are not derived from the cell membrane (Zhang et 
al. 2018). Exosomes are generated when multivesicular bodies (MVBs) fuse with 
the cell membrane and release vesicles, called exosomes, into the extracellular 
space (Théry, Zitvogel, and Amigorena 2002; Maas, Breakefield, and Weaver 
2017). Conversely, microvesicles are produced through the outward budding and 
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scission of the cell membrane (Raposo and Stoorvogel 2013; Maas, Breakefield, 
and Weaver 2017). EVs modulate intercellular communication through the transfer 
of RNA and proteins from donor to recipient cells (Cocucci and Meldolesi 2015; 
Théry, Zitvogel, and Amigorena 2002; Raposo and Stoorvogel 2013). For instance, 
EVs released from primary cultures of neonatal subventricular zone (SVZ) neural 
stem cells (NSCs) play an immuno-modulatory role in NSC-microglia 
communication (Morton et al. 2018). Furthermore, other studies have identified the 
release of particles during neurogenesis whose targets and functions are unknown 
(Das and Storey 2014; Dubreuil et al. 2007). EVs are found in most biological fluids 
including cerebrospinal fluid (CSF), but again, the sources, targets, and functions 
remain elusive (Feliciano et al. 2014; Tietje et al. 2014). 
 CD9 is a tetraspanin protein enriched in fractions of EVs (Raposo and 
Stoorvogel 2013). First discovered in hematopoietic cells derived from acute 
lymphoblastic leukemia, CD9 is one of the most commonly identified EVs marker 
proteins along with CD63 and CD81 (Kersey et al. 1981; Cocucci and Meldolesi 
2015; Raposo and Stoorvogel 2013; Maas, Breakefield, and Weaver 2017; Théry, 
Zitvogel, and Amigorena 2002). It was later discovered that CD9 was released into 
the CSF of acute lymphoblastic leukemia patients (Komada et al. 1990). Of note, 
EV marker proteins are beneficial in identifying and studying EVs. However, EV 
marker proteins can distinguish similar and unique EV populations (Booth et al. 
2006; Fang et al. 2007; Bobrie et al. 2012; Crescitelli et al. 2013). Interestingly, not 
all EVs are CD9-positive (Crescitelli et al. 2013). Similarly, through 
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immunohistochemistry, one study demonstrated the lack over overlap between 
CD9-positive and CD63-positive staining in cells (Bobrie et al. 2012). CD9 and 
CD63 are enriched in MVBs and are found throughout the secretory pathway 
including the cell membrane and lysosomes (Andreu and Yáñez-Mó 2014). 
Additional studies have also identified CD9 in EV fractions isolated from rodent 
and human CSF (Feliciano et al. 2014; Tietje et al. 2014). Studies involving the 
nervous system and nervous system development have identified the expression 
of CD9 in SVZ NSCs (Morton et al. 2018; Cossetti et al. 2014; Llorens-Bobadilla 
et al. 2015).  
 Fluorescently tagged EV marker proteins have historically been used 
to study EVs. CD9 fused to copepod GFP (CD9-GFP) has recently been used to 
label EVs in vitro and in vivo (Morton et al. 2018). In lower-order model systems, 
such as Drosophila, CD63-GFP has been used in studies of bone morphogenic 
protein (BMP), Hedgehog, Wingless, and Wnt signaling (Corrigan et al. 2014; 
Gross et al. 2012; Panáková et al. 2005). CD63-GFP has also been implicated in 
exosome studies in mammalian cells, including mouse, rat, and human cells 
(Yoshimura et al. 2016; Melo et al. 2015; Kosaka et al. 2013). One study reported 
the unidirectional transfer of miRNA from T cells to antigen presenting cells through 
exosomes tagged with CD63-GFP (Mittelbrunn et al. 2011). Transgenic model 
systems have also been implicated in the study of EVs and EV marker proteins. 
Early studies of transgenic CD9 mice discovered that knockout animals were 
infertile (Miyado et al. 2000). To investigate the role CD9 plays in reproduction, 
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researchers generated a CD9-eGFP mouse (Miyado et al. 2008). It was 
discovered that CD9-containing vesicles released from oocytes are required for 
proper egg-sperm fusion (Miyado et al. 2008). More recently tag-GFP from 
copepods was fused to human CD63 and used to create transgenic rats 
(Yoshimura et al. 2016). CD63-GFP expression is controlled via a constitutively 
activate CAG promoter. CD63-GFP was located within perinuclear regions within 
cells and could be detected in EVs fractions. Interestingly, transgenic animals were 
found to have shortened lifespans (4-6 months). To study CD63-GFP expression 
in neuronal cells, CD63-GFP was inserted downstream of a Sox2 promoter 
(Yoshimura et al. 2018). Sox2 driven CD63-GFP expression successfully labeled 
neuronal cells during embryonic development, and unlike CAG driven CD63-GFP, 
Sox2-CD63-GFP animals did not have shortened lifespans. These studies 
demonstrate the utility of transgenic animals to label and track EVs in vivo in a cell-
type specific manner. 
The SVZ is one of two neurogenic regions in the postnatal brain (Taverna, 
Götz, and Huttner 2014; Lim and Alvarez-Buylla 2016; Bjornsson et al. 2015). The 
SVZ is comprised of multiple cell types including neural-derived cells, such as 
astrocytes and ependyma, and non-neural-derived cells, such as microglia, 
endothelial cells, and pericytes (Bjornsson et al. 2015). Cells in the adult SVZ are 
arranged in a pinwheel structure surrounding NSCs (Mirzadeh et al. 2008). What 
developmental factors contribute to the generation of this architecture is only 
partially understood. Due to their abundance in the CSF, some studies point to 
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EVs as a source of neuro-developmental factors (Bátiz et al. 2016). Indeed, in a 
study conducted on rat embryonic CSF (eCSF) EVs, it was demonstrated that 
isolated eCSF EVs have a proliferative effect in mixed cultures of NPCs (Feliciano 
et al. 2014). Moreover, Coultier and colleagues demonstrated that mutations in the 
exosome biogenesis pathway resulted in microcephaly in patients via a reduction 
in Sonic Hedgehog (SHH) signaling (Coulter et al. 2018).  
To study EV release from SVZ NSCs in vivo, a CRE-recombinase inducible 
transgenic mouse to label and track EVs was generated. CD9 was fused to the 
copepod GFP (CD9-GFP) and inserted downstream of a stop sequence flanked 
by loxP excision sites. The transgene backbone was modeled of off previous 
studies (Sasaki et al. 2006; Zambrowicz et al. 1997). 48 hrs following 
electroporation of CRE-recombinase into postnatal day 0 (P0) transgenic mice, 
CD9-GFP could be detected in Nestin-positive cells in the SVZ. This study 
demonstrates the potential of Nestin-positive SVZ NSCs to release EVs. 
Furthermore, the generation of this in vivo EV labeling system will allow for studies 
of EVs to be carried out in a spatial- and temporal-specific manner.  
 
RESULTS 
Generation and Validation of Transgenic CD9-GFP Mouse 
To study EVs in vivo, a CRE inducible CD9-GFP plasmid using the 
backbone of a previously described targeting plasmid was generated (Sasaki et al. 
2006; Zambrowicz et al. 1997) (Fig. 1A). Since cytomegalovirus (CMV) promoters 
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do not stimulate robust transcription of their downstream gene in the nervous 
system, CD9-GFP was placed into a plasmid containing a pCAGGs promoter used 
in the generation of transgenic mice (Gray et al. 2011). Previous reports have  
identified the utility of pCAGGs-CD9-GFP plasmids in studies of EVs (Morton et al. 
2018). The new plasmid contains targeting arms for homologous recombination 
and insertion of CD9-GFP into the mouse Rosa26 locus and a neomycin 
resistance (NeoR) cassette for selection. Moreover, upstream of CD9-GFP is a 
stop sequence flanked by loxP sites. The configuration of the targeting plasmid 
therefore allows insertion of an inducible CD9-GFP that is activated by CRE 
mediated recombination.  
In trial experiments, mouse neuroblastoma Neuro 2A (N2A) cells robustly 
express CD9-GFP when co-transfected with CAG-CRE (Fig. 1B-C). The mouse 
was generated through electroporation of the targeting plasmid into mouse 
embryonic stem cells (ESCs). Positive clones were screened for neomycin 
resistance. Long-range PCR was performed to validate proper insertion of the 
transgene into the Rosa26 locus. In-house long-range PCR was utilized to 
genotype CD9-GFP mice (Fig. 1D-E). Transgenic mice containing CD9-GFP were 
crossed with inducible Tomato+/+ mice to generate CD9-GFP+/-; Tomato+/- mice. 
Tomato is only expressed with the addition of CRE-recombinase, similar to CD9-
GFP. Thus, cells carrying CD9-GFP and Tomato should express both transgenes 
with the addition of CRE-recombinase.  
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To test whether CD9-GFP+/-; Tomato+/- expression can be induced, CAG-
CRE and was electroporated into the neonatal SVZ of P0 CD9-GFP mice. Within 
48 hrs, CD9-GFP and Tomato expression was detected in cells surrounding the 
lateral ventricle (Fig. 1F-H), CD9-GFP expression was surprisingly lower in 
abundance than anticipated. In contrast to Tomato expression, CD9-GFP 
expression could only be detected in a subset of Tomato positive (Fig. 1F) and 
Tomato negative cells (Fig. 1G-H). Taken together, these results indicate CD9-
GFP mice were generated, and in the presence of CRE-recombinase, CD9-GFP 
could be detected in cells within the SVZ of postnatal mice.  
 
CD9-GFP Labels Nestin+ cells in perinatal SVZ  
Tissue collected from CD9-GFP mice electroporated with CAG-CRE were 
subjected to immunohistochemistry to study cell types expressing the transgene. 
It was found that CD9-GFP particles colocalized with Nestin-positive cells in the 
SVZ (Fig. 2A). Given that CD9-GFP was localized to the apical side of the soma, 
contiguous with the lateral ventricle (Fig. 2A), it is likely that SVZ NSCs release 
EVs containing CD9-GFP into the CSF of postnatal mice.    
DISCUSSION 
In the present study, we have reported use of a transgenic inducible system 
to label and track EVs in vivo. EVs are released from most, if not all, cell types 
(Raposo and Stoorvogel 2013; Théry, Zitvogel, and Amigorena 2002). 
Furthermore, their abundance in biological fluids, including CSF, blood, and urine, 
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renders difficulty for researchers when identifying their sources, targets, and 
functions. Historically, EVs have been isolated from media collected from in vitro 
cell cultures, labeled using lipophilic dyes, and then transplanted either in vivo or 
in vitro; however, these techniques are limited in that over-abundance of 
transplanted EVs may result in super-physiological responses (Morton, Neckles, 
and Feliciano 2018). Additionally, transfection and electroporation techniques 
have also been implemented to label and track EVs. However, due to plasmid 
dilution over time, these techniques make tracking labeled cells more challenging 
in lengthier studies (Lacar et al. 2010). Generating a genetic in vivo model to label 
and track EVs to circumvent issues observed with other labeling techniques will be 
paramount to future studies of EVs.  
In the nervous system, many cells types release EVs during development 
and throughout life (Morton and Feliciano 2016). Recent studies have reported the 
release of EVs from primary cultures of SVZ NSCs in both adult and neonatal 
cultures (Cossetti et al. 2014; Morton et al. 2018), but evidence of in vivo release 
is lacking. In this study, a transgenic model system, in which CD9-GFP was 
inserted downstream of a stop sequence flanked by loxP sites and driven by a 
pCAGGs promoter, was used to identify EVs in SVZ NSCs. Studies in N2A cultures 
demonstrated that co-transfection of CAG-CRE and CD9-GFP DNA plasmids 
resulted in robust CD9-GFP expression. Transgenic CD9-GFP mice were crossed 
with CRE-recombinase inducible Tomato+/+ to generate CD9-GFP+/-; Tomato+/- 
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mice. CAG-CRE was electroporated into P0 CD9-GFP+/-; Tomato+/- mice. CD9-
GFP was expressed in Nestin-positive SVZ NSCs. 
 Previous reports have used other EV marker proteins to label and track EVs 
in vivo. However, it is important to note that different EV marker proteins label 
different populations of EVs, thus the ability to label and track specific marker 
proteins may only provide insight into a small subset of EVs (Wei et al. 2017; 
Momen-Heravi et al. 2015). Recently, Yoshimira and colleagues generated a 
transgenic rat model in which CD63 was fused to copepod GFP and inserted 
downstream of a CAG promoter (Yoshimura et al. 2016). Unlike the mouse model 
system described here, the CD63-GFP is continuously expressed in the rat model 
from conception to adulthood. The constitutive expression has many pros and 
cons. For example, during embryonic development where outside perturbances, 
such as electricity or tamoxifen, can cause lethality, constitutive expression of the 
CD63-GFP transgene allows for EV detection without any threat to embryonic 
development. Although, CD63-GFP transgenic rats were shown to have a 
reduction in life expectancy. However, since CD63-GFP is expressed in all cell 
types during all stages of development and adulthood, sources, targets, and 
functions are difficult to decipher. To circumvent the ubiquitous expression of 
CD63-GFP, Yoshimira and colleagues published another manuscript in which 
CD63-GFP was expressed under the control of the Sox2 promoter (Yoshimura et 
al. 2018). Sox2 regulated expressed of CD63-GFP was used to label and track 
neuronal CD63-positive EVs during development. This approach demonstrated 
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specific expression of CD63-GFP and allowed for better tracking of fluorescently 
labeled EVs released from Sox2 cell lineages during embryonic neurogenesis.  
Conversely, the model described here offers the ability to temporally and 
spatially regulate the expression of the transgene, thus allowing for studies of 
individual cell types or cell populations during development. For instance, Nestin 
is a marker protein enriched in NSCs in the developing brain. To study the release 
of CD9-GFP from NSCs, transgenic mice carrying CRE-recombinase driven by a 
Nestin specific promotor (Nestin-CRE+/+) could be crossed with CD9-GFP+/+ mice. 
Nestin-CRE+/-; CD9-GFP+/- mice would offer researchers spatial control over CD9-
GFP expression. Additionally, to temporally regulate CD9-GFP expression, Nestin-
CRE-ERT2 mice could be used. ERT2 is a modified estrogen receptor (Feil, 
Valtcheva, and Feil 2009). In the presence of Tamoxifen, the receptor dimerizes 
and translocates into the nucleus, and in the case of Nestin-CRE-ERT2, the 
translocation of Cre-ERT2 into the nucleus would result in CD9-GFP expression in 
Nestin-expressing cells. The integration of Nestin-CRE-ERT2 would allow for a 
temporal regulation of CD9-GFP expression. 
The growing understanding of EV biology is only limited by the tools 
available. As the understanding of processes and functions expands, scientific 
tools must do the same. It is our hope that with the generation of better tools and 
scientific collaboration, the scientific community will only continue to move forward. 
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METHODS 
Mice 
Research protocols were approved by the Clemson University Institutional Animal 
Care and Use Committee and NIH Guide for the Care and Use of Laboratory 
Animals. For neonatal electroporations, pregnant CD-1 were provided by Charles 
River Laboratories. Tomato mice (B6.Cg-Gt(ROSA)26Sortm9(CAG-td-Tomato) 
Hze/J; Stock No: 007909 Ai9) were obtained from Jackson Laboratories and 
crossed to CD9-GFP mice.  
 
Cell Culture, Transfections and Immunocytochemistry 
N2A mouse neuroblastoma cells (American Type Culture Collection CCL-
131) were maintained in tissue culture-treated polystyrene multi-well plates or 
flasks (Falcon; BD Biosciences Discovery Labware) in a 37°C incubator with 5% 
CO2. When N2A cells reached 80-90% confluence, they were passaged onto 
circular coverslips in six-well plates 24 hours prior to transfection. Cells were then 
transfected with PolyJet (SignaGen Laboratories) with DNA vectors (CD9-GFP 
and CAG-CRE) according to manufacturer’s recommendations. 48 hours post-
transfection, cells were fixed using 4% paraformaldehyde in 1x DMEM by replacing 
half of the media three consecutive times for 10 minutes. Coverslips were washed 
three times for 5 minutes in wash buffer (PBS, 0.1% Tween-20) and incubated with 
1 nM TO-PRO-3 Iodide (Topro) in DMSO (Life Technologies) for 10 minutes. 
Coverslips were then washed in wash buffer five times for a total of 45 minutes 
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and then 1X PBS and mounted in ProLong Gold antifade reagent (Life 
Technologies) and imaged at described.  
 
Postnatal Electroporations 
Electroporations were performed on CD1 mice as previously described with minor 
modifications (Feliciano, Lafourcade, and Bordey 2013). Briefly, high purity DNA 
(OD 260/280 > 1.80) high concentration (1-10 μg/μl) DNA was prepared in sterile 
PBS and preloaded into a 10 cm fire polished borosilicate glass capillary tubes 
(O.D.: 1.5 mm, I.D.:1.10 mm) pulled with a Sutter Instrument Company Model P-
97 glass pipette puller. Forceps were used to manually break tips prior to use. 10 
μg/μL DNA solution containing CAG-CRE was combined with 0.1% weight/volume 
fast green solution and diluted in 1x dPBS. CD9-GFP Postnatal day 0-1 pups were 
placed onto a Petri dish and placed on wet ice. DNA mixture was loaded into the 
pulled glass and injected into the left lateral ventricle. Pups were electroporated 
with a BTX ECM 830 Square Wave Pulse generator and Tweezertrodes (Harvard 
Apparatus) using 5 square pulses, 50 msec/pulse at 100 volts, with 950 msec 
intervals. The negative electrode on the contralateral hemisphere ventral lateral to 
the pup’s snout was used to direct DNA into the SVZ and electrodes were swept 
from dorsal to lateral positions using ~25° angle intervals. Pups were placed onto 
a heating pad for 5 min until recovered and placed back into cages. 
 
Transgenic mice 
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Transgenic mice were generated through the assistance of the Yale Transgenic 
Core Facility and Charles River. Human CD9 fused to copepod GFP (CD9-GFP) 
was inserted into a modified version of pROSA26-1 containing loxP-flanked neoR-
stop cassette as previously described (Sasaki et al. 2006). Mouse embryonic stem 
cells were electroporated, cultured and selected for using neomycin resistance. 
Long range PCR was used to identify positive clones for GFP and proper insertion 
into the Rosa26 locus. F1 mice were crossed with Tomato+/+ mice ((B6.Cg-
Gt(ROSA)26Sortm9(CAG-td-Tomato) Hze/ice) to generate double transgenic 
strains.  
 
Slice Preparation and immunohistochemistry 
Brains were fixed in 4% paraformaldehyde in 1X PBS for 4 hours at room 
temperature. Brains were rinsed overnight in 1X PBS at 4°C. 3% low-melt agar 
was used to mount brains for sectioning. Brains were sliced into 200 μm coronal 
sections on a Leica VTS1000 vibratome. Sections were incubated for 1 hour in 
blocking buffer (2% Bovine Serum Albumin, 0.1% Triton-X, 0.1% Tween20 and 1X 
PBS) at room temperature. Following blocking, sections were rinsed three times 
with wash buffer (0.1% Tween 20 and 1X PBS) at room temperature, and 
incubated with antibody solution (2% Bovine Serum Albumin, 0.1% Tween20 and 
1X PBS) overnight at 4ºC along with Nestin (1:500, Novus, Catalog # NB100-1604) 
primary antibody. Following incubation, slices were washed in wash buffer three 
times for 5 min each time at room temperature. Sections were subsequently 
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incubated with secondary antibodies conjugated to Alexa Fluor-647 (1:500, Life 
Technologies) for 1 hr at room temperature. Sections were then rinsed in wash 
buffer five times for 10 min each at room temperature. Sections were mounted in 
ProLong Anti-fade mounting reagent (ThermoFischer Scientific). 
 
Imaging 
Images were taken on a Leica TCS SPE spectral confocal microscope using 63x 
oil immersion lense. Images were processed using Leica Application Suite X 
software (Leica Microsystems) to render confocal sections into 2D and 3D Z-
stacks. 
 
Long-range PCR 
Long range PCR was performed according to manufacturer’s instructions. In brief, 
toe snips were collected from transgenic mice. DNA was isolated using DNeasy 
Blood and Tissue kit (Qiagen, Catalog #69506) . Tissues were place in Buffer ATL 
and Proteinase K solution and incubated at 56ºC until tissues were completely 
digested. Buffer AL was added to the samples and vortexed for 15 s. Ethanol (95%) 
pre-chilled at -20ºC was added and the samples were again vortexed. Samples 
were transferred into a DNeasy Mini spin column with collection tube and 
centrifuged at 6,000 x g for 1 min. Flow through was discarded. Samples were 
washed with Buffer AW1 and again centrifuged for 1 min at 6,000 x g. Flow through 
was discarded. Samples were then washed with Buffer AW2 and centrifuged at 
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14,000 x g for 5min. Flow through was discarded. Buffer AE was added to DNeasy 
Mini spin column and incubated at room temperature for 5 min. Samples were 
centrifuged at 6,000 x g for 1 min. Samples were subjected to nanodrop technology 
to determine DNA concentrations.  
 Samples were then subjected to Long Range PCR. Using a Long Range 
PCR Kit a reaction mix was made as follows: 1x LongRange PCR Buffer with Mg2+, 
500 µM of 10 mM dNTP mix, 1x Q-solution, 0.4 µM forward and reverse 
LongRange primers (see Table 1.), 2 units per 50 µL reaction of LongRange PCR 
Enzyme Mix and nuclease free water to bring each reaction to 50 µL total volume 
(Qiagen, Catalog #206403). 1.5 µL of DNA sample was added to each reaction. 
Thermocycler protocol was programmed following manufacturer’s instructions. 
1.5% agarose gel was made using 1x TAE buffer. SYBR safe DNA gel stain 
(Thermo Fisher, Catalog #S33102) was added to get to visualize DNA. Samples 
were loading with BlueJuice gel loading buffer (Thermo Fisher, Catalog 
#10816015) and run at 104 V for 20 min. 
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Figures: 
 
Figure 1. Generation of Cre-Inducible CD9-GFP Mice. A) Schematic diagram of 
Cre-inducible CD9-GFP targeting plasmid. B-C) Transfections of N2A cells with 
CD9-GFP (green), Tomato (red) and CAG-CRE. Nuclei were counterstained with 
TOPRO-3 (blue) Scale bar 10 µm. D) Long-rage PCR of ESC clones using a 5’ end 
primers. Lanes 4-6 depict long-range PCR product expected in CD9-GFP positive 
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mice. Arrow = 1.5 kb. E) Genotyping PCR of CD9-GFP+/-; Tomato+/- mice. Wild type 
= 297 bp. Tomato heterozygote = 297 bp and 196 bp. Tomato homozygote = 196 
bp. F) 20x image of brain section from CD9-GFP+/-;Tomato+/- mice 48 hrs post-
electroporation with CAG-CRE. CD9-GFP (green) is observed in a subset of 
Tomato-positive (red) cells. Scale bar 50 µm. G-H) CD9-GFP+/-; Tomato+/- mice 48 
hrs after electroporation with CAG-CRE. CD9-GFP (green) is detected in 
perinuclear regions in cells within the SVZ. DNA is counterstained with TOPRO-3 
(blue). Scale bar 50 µm.   
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Figure 2. CD9-GFP Labels Nestin-positive cells in perinatal SVZ. A) CD9-GFP 
(green) particles are found within Nestin-positive (blue) and Tomato-positive (red) 
cells in the SVZ of postnatal day 2 (P2) mice following electroporation with CAG-
CRE.  Scale Bar 50µm.  
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TABLES: 
PRIMER SEQUENCE Size 
5' End  
F = CGCCTAAAGAAGAGGCTGTG 
1.5 kb 
R = TCATCAAGGAAACCCTGGAC 
3' End 
F = AACAAGCACTGTCCTGTCCTCA 
4.9 kb 
R = TAGTTGCCAGCCATCTGTTGTT 
Tomato 
F = CTGTTCCTGTACGGCATGG 
196 kb 
R = GGCATTAAAGCAGCGTATCC 
Wild Type 
F = CCGAAAATCTGTGGGAAGTC 
296 kb 
R = AAGGGAGCTGCAGTGGAGTA 
 
Table 1. Primers Used for Long Range PCR and Genotyping 
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CONCLUSION 
Previous studies in our lab found the presence of extracellular vesicles 
(EVs) in the cerebrospinal fluid (CSF) of embryonic and adult mammals (Feliciano 
et al. 2014). EV abundance was found to under-go age-dependent declines, which 
suggested to us that EVs have both a developmental and homeostatic role (Tietje 
et al. 2014). Additionally, EVs isolated from the CSF of rodent embryos had a 
proliferative effect when used to treat neuroprogenitor cells in vitro (Feliciano et al. 
2014). Moreover, many of the contents found within EVs isolated from CSF were 
found to be conserved between rodent and human embryos (Feliciano et al. 2014). 
These finding prompted us to ask what are the sources, targets, and functions of 
EVs. Due to the availability of tools to study neural stem cells (NSCs) both in vivo 
and in vitro and the lack of documentation of EV release from NSCs, I chose to 
focus this dissertation on NSCs. Subventricular zone (SVZ) NSCs line the lateral 
ventricle and interact with the CSF during early postnatal development. Thus, SVZ 
NSCs may be a source of CSF EVs. In Chapter 2, I developed a protocol to study 
the release of primary SVZ NSC EVs. Currently, there is no standard for EV 
isolation. Many studies have implored the use of ultracentrifugation to isolate EVs 
and a subsequent clean-up step to isolate exosomes. Due to issues with 
reproducibility (Livshits et al. 2015; Bobrie et al. 2012), ultracentrifugation alone 
was not sufficient to isolate and study EVs. Using a sucrose density gradient, I 
isolated exosomes from primary SVZ NSC media. Sucrose density gradients can 
cause vesicle rupture and EV fusion during (Taylor and Shah 2015; Théry et al. 
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2006; Linares et al. 2015), but are one of the most widely used methods for 
exosome isolation. Then, by labeling EVs or exosomes with the lipophilic dye, DiI, 
I was able to visualize transplanted vesicles in early postnatal brains. In Chapter 
3, I implemented this protocol to study the effects of primary SVZ NSC EVs in vivo. 
DiI labeled cells were primarily Iba1-positive microglia. DiI labeled microglia were 
found to have a rounded morphology. Small RNA sequencing uncovered miRNA 
families, such as the Let-7 family, were enriched within primary SVZ NSC EVs. 
When transfected into miRNA-depleted EVs, Let-7 could induce the microglia 
morphological shift from a stellate to a rounded morphology. Moreover, microglia 
morphology was partially rescued when EVs were subjected to UV treatment prior 
to transplantation. NSC EV treated microglia also underwent a transcriptional 
change. This alteration coincided with a change in the cytokine profile of treated 
vs untreated microglia. Interestingly, when media condition by either treated or 
untreated microglia was injected into the lateral ventricles of neonatal mice, the 
EV-treated media caused a reduction in the number of dividing NSCs within the 
SVZ. These data demonstrate a negative feedback loop in which NSCs release 
EVs that are taken up by microglia in the SVZ. Microglia then undergo a 
transcriptional change which in turn alters their cytokine prolife. This change 
results in the reduction of dividing NSCs, although the mechanism by which this 
occurs has yet to be uncovered. Finally, in Chapter 4 we implore the use of a 
transgenic model system to study the production and released of EVs from SVZ 
NSCs in vivo. Through the postnatal electroporation of Cre-Recombinase, we 
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discovered that Nestin-positive cells lining the lateral ventricle co-localized with 
CD9-GFP-positive particles. Although it remains to be determined the frequency 
and abundance of EV release from SVZ NSCs, I propose that SVZ NSCs release 
EVs in vivo.  
Early Postnatal SVZ NSCs Release Extracellular Vesicles  
My focus while conducting these studies was to determine if neonatal SVZ 
NSCs release EVs. Previous reports have discovered the released of EVs from 
primary cultures of adult SVZ NSCs (Cossetti et al. 2014; Llorens-Bobadilla et al. 
2015), but whether or not neonatal SVZ . Here we provide evidence to support the 
release of EVs from neonatal SVZ NSCs. Western blots of dorsal forebrain extracts 
showed an upregulation of tetraspanin CD9, an EV marker protein, beginning at 
postnatal day 2 (P2) and increasing exponentially into adulthood. Additionally, 
Nestin expressing cells in the SVZ stained positive for EV marker protein CD9. 
Electroporation of CD9-GFP into P0 SVZ NSCs showed a bipolar distribution in 
the apical and basal projecting processes in Nestin-positive cells 48 hrs later. GFP 
was also detected in perinuclear regions within the soma of Nestin-positive cells. 
In some cases, GFP was located outside of cells, suggestive of release. However, 
since SVZ NSCs generate multiple cells types in the SVZ, cortex, and olfactory 
bulbs, it was inconclusive as to which cell types released CD9-GFP positive 
particles. Therefore, I dissected and placed SVZ NSCs in culture. Approximately 
92% of cells in the primary cultures stained positive for Nestin. Endogenous CD9 
was detected in Nestin-positive cells exhibiting a bipolar morphology, similar to in 
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vivo phenotypes. Western blot confirmed the presence of Nestin-positive cells in 
primary SVZ cultures. Culture media was subjected to EV isolation via 
ultracentrifugation. EV pellets produced following an 18 hr centrifugation at 
100,000 x g were subjected to western blotting and electron microscopy. CD63 
was detected in both primary SVZ NSC cell lysates and isolated EVs. Additionally, 
EVs were enriched for CD9 and Alix when compared to cell lysates. Electron 
microscopy images showed the presence of multiple types of EVs, including 
microvesicles, exosomes, and exomeres, within the isolated EV pellet. Finally, 
since primary SVZ NSC cultures were not purely NSCs, further validation of in vivo 
EV release was required. Transgenic mice expressing CD9-GFP under control of 
Cre-mediated recombination of loxP sites flanking a stop codon were 
electroporated with CAG-CRE. CD9-GFP was detected in Nestin-positive cells 
exhibiting an SVZ NSC morphology in P2 brain sections. Furthermore, CD9-GFP 
was predominately localized to the apical surface which directly interfaces the 
CSF. Taken together, these results suggest that SVZ NSCs release EVs. 
Final Concluding Thoughts 
 The field of EV biology has rapidly expanded over the last decade, and while 
many studies have led to profound discoveries, there is still much left to uncover. 
Specifically during nervous system development, studies have demonstrated the 
importance of factors within the CSF to control NSC proliferation (Lehtinen et al. 
2011). When added to cultures of neural progenitor cells, EVs isolated from rodent 
CSF had a proliferative effect (Feliciano et al. 2014). Other studies have identified 
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the generation of particles during neurogenesis with unknown developmental 
implications (Das and Storey 2014; Dubreuil et al. 2007). Recently it was 
discovered that genetic loss of exosome release resulted in microcephaly in 
patients, suggesting that EVs play an important neurodevelopmental role (Coulter 
et al. 2018).  
 My dissertation focuses on the release of EVs from neonatal SVZ NSCs 
(Morton, Neckles, and Feliciano 2018; Morton et al. 2018). We demonstrated the 
regulatory effects of SVZ NSC EVs on microglia. While the results are provocative, 
it is important to state that transplantation experiments involving EVs raises the 
concentration of EVs exponentially. Therefore, the data obtained may only offer 
insight into the super-physiological response of microglia to SVZ NSC EVs. 
However, the data does suggest a developmental role in which SVZ NSC EVs act 
as a microglia morphogen within the SVZ. The early migration of microglia to the 
neonatal SVZ might then be a result of EVs released from SVZ NSCs. Upon arrival 
into the SVZ, microglia possibly regulate SVZ NSC proliferation and allow for the 
sufficient production of olfactory bulb neurons and other NSC-derived cell types. 
These data support the release of EVs from SVZ NSCs in vitro. Using our 
transgenic model system, we induced CD9-GFP expression in neonatal SVZ 
NSCs through electroporation of Cre recombinase. We found a low number of SVZ 
NSCs that expressed CD9-GFP. Of the cells expressing CD9-GFP, it was 
discovered that CD9-GFP localized to the apical side of Nestin-positive cells in the 
SVZ. It was surprising to see such a low number of NSCs expressing CD9-GFP; 
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however, this could simply be due to inefficient incorporation of the CD9-GFP 
transgene into the Rosa26 locus. Since the Tomato transgene also occupies the 
Rosa26 locus, there is the possibility that only one transgene is expressed in one 
cell at any given time. The likelihood of both Tomato and CD9-GFP expression, 
although possible, is very low. Since experiments were conducted on Tomato+/-
;CD9-GFP mice, it would be important to re-visit this issue with a CD9-GFP-
positive Tomato-/- animal. Finally, while the generation of this transgenic model 
system that allows for the tracking of EVs in vivo, it is important to note that not all 
EVs carry CD9 and thus CD9-GFP will not label all EVs. Other model systems 
utilizing other EV marker proteins will be required to study all populations of EVs 
in vivo. 
 My dissertation demonstrates the release of EVs from SVZ NSCs and 
uncovers a neuro-developmental role for these nanometer sized messengers. 
Future studies will be required to further validate these findings in vivo. Knock-
down and over-expression experiments will be needed to prove the necessity and 
sufficiency of NSC EV release and uptake in vivo. While the field of EV biology is 
relatively new, it has already altered our understanding of intercellular 
communication. Further advances to scientific tools will allow for more precise and 
in-depth characterization of these lucrative vesicles. 
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